<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients - de Heer, K - 2019 | Cochrane Library</title> <meta content="Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients - de Heer, K - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012399.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients - de Heer, K - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012399.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012399.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients" name="citation_title"/> <meta content="Koen de Heer" name="citation_author"/> <meta content="kdeheer@flevoziekenhuis.nl" name="citation_author_email"/> <meta content="Marije G Gerritsen" name="citation_author"/> <meta content="Academic Medical Center" name="citation_author_institution"/> <meta content="Caroline E Visser" name="citation_author"/> <meta content="Academic Medical Centre" name="citation_author_institution"/> <meta content="Mariska MG Leeflang" name="citation_author"/> <meta content="Amsterdam University Medical Centers, University of Amsterdam" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD012399.pub2" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/05/20" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012399.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012399.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012399.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Immunocompromised Host; Aspergillosis [*diagnosis, immunology]; Biomarkers [blood]; Bronchoalveolar Lavage Fluid [*microbiology]; Galactose [analogs &amp; derivatives]; Invasive Fungal Infections; Mannans [*blood]; Randomized Controlled Trials as Topic; Sensitivity and Specificity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012399.pub2&amp;doi=10.1002/14651858.CD012399.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="UDgTyLGV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012399\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012399\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","fa","ms","ru"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012399.pub2",title:"Galactomannan detection in broncho\\u2010alveolar lavage fluid for invasive aspergillosis in immunocompromised patients",firstPublishedDate:"May 20, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Airways Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012399.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012399.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012399.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012399.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012399.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012399.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012399.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012399.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012399.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012399.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>4709 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012399.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-sec-0112"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-sec-0039"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-sec-0041"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-sec-0068"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-sec-0087"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/appendices#CD012399-sec-0117"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/table_n/CD012399StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/table_n/CD012399StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Diagnostic</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Galactomannan detection in broncho‐alveolar lavage fluid for invasive aspergillosis in immunocompromised patients </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information#CD012399-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Koen de Heer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information#CD012399-cr-0003">Marije G Gerritsen</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information#CD012399-cr-0004">Caroline E Visser</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information#CD012399-cr-0005">Mariska MG Leeflang</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information/en#CD012399-sec-0133">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 20 May 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012399.pub2">https://doi.org/10.1002/14651858.CD012399.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012399-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012399-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012399-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012399-abs-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012399-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012399-abs-0001" lang="en"> <section id="CD012399-sec-0001"> <h3 class="title" id="CD012399-sec-0001">Background</h3> <p>Invasive aspergillosis (IA) is a life‐threatening opportunistic mycosis that occurs in some people with a compromised immune system. The serum galactomannan enzyme‐linked immunosorbent assay (ELISA) rapidly gained widespread acceptance as part of the diagnostic work‐up of a patient suspected of IA. Due to its non‐invasive nature, it can be used as a routine screening test. The ELISA can also be performed on bronchoalveolar lavage (BAL), allowing sampling of the immediate vicinity of the infection. The invasive nature of acquiring BAL, however, changes the role of the galactomannan test significantly, for example by precluding its use as a routine screening test. </p> </section> <section id="CD012399-sec-0002"> <h3 class="title" id="CD012399-sec-0002">Objectives</h3> <p>To assess the diagnostic accuracy of galactomannan detection in BAL for the diagnosis of IA in people who are immunocompromised, at different cut‐off values for test positivity, in accordance with the <a href="http://methods.cochrane.org/sdt/handbook-dta-reviews" target="_blank">Cochrane Diagnostic Test Accuracy Handbook</a>. </p> </section> <section id="CD012399-sec-0003"> <h3 class="title" id="CD012399-sec-0003">Search methods</h3> <p>We searched three bibliographic databases including MEDLINE on 9 September 2016 for aspergillosis and galactomannan as text words and subject headings where appropriate. We checked reference lists of included studies for additional studies. </p> </section> <section id="CD012399-sec-0004"> <h3 class="title" id="CD012399-sec-0004">Selection criteria</h3> <p>We included cohort studies that examined the accuracy of BAL galactomannan for the diagnosis of IA in immunocompromised patients if they used the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) classification as reference standard. </p> </section> <section id="CD012399-sec-0005"> <h3 class="title" id="CD012399-sec-0005">Data collection and analysis</h3> <p>Two review authors assessed study quality and extracted data. Quality Assessment of Diagnostic Accuracy Studies‐2 (QUADAS‐2) was used for quality assessment. </p> </section> <section id="CD012399-sec-0006"> <h3 class="title" id="CD012399-sec-0006">Main results</h3> <p>We included 17 studies in our review. All studies except one had a high risk of bias in two or more domains. The diagnostic performance of an optical density index (ODI) of 0.5 as cut‐off value was reported in 12 studies (with 1123 patients). The estimated sensitivity was 0.88 (95% confidence interval (CI) 0.75 to 1.00) and specificity 0.81 (95% CI 0.71 to 0.91). The performance of an ODI of 1.0 as cut‐off value could be determined in 11 studies (with 648 patients). The sensitivity was 0.78 (95% CI 0.61 to 0.95) and specificity 0.93 (95% CI 0.87 to 0.98). At a cut‐off ODI of 1.5 or higher, the heterogeneity in specificity decreased significantly and was invariably &gt;90%. </p> </section> <section id="CD012399-sec-0007"> <h3 class="title" id="CD012399-sec-0007">Authors' conclusions</h3> <p>The optimal cut‐off value depends on the local incidence and clinical pathway. At a prevalence of 12% a hypothetical population of 1000 patients will consist of 120 patients with IA. At a cut‐off value of 0.5 14 patients with IA will be missed and there will be 167 patients incorrectly diagnosed with IA. If we use the test at a cut‐off value of 1.0, we will miss 26 patients with IA. And there will be 62 patients incorrectly diagnosed with invasive aspergillosis. The populations and results were very heterogeneous. Therefore, interpretation and extrapolation of these results has to be performed with caution. A test result of 1.5 ODI or higher appears a strong indicator of IA. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012399-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012399-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012399-abs-0009">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012399-abs-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012399-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012399-abs-0010">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD012399-abs-0004">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012399-abs-0002" lang="en"> <h3>Measuring galactomannan in lung‐washing fluid to diagnose invasive aspergillosis in patients with an impaired immune system </h3> <p><b>Why is improving the accuracy of the diagnosis of invasive fungal disease important?</b> </p> <p>Some people have a weakened immune system; they are said to be 'immunocompromised'. People can be immunocompromised when they have leukaemia, or HIV/AIDS, and when using some forms of medication. </p> <p>Immunocompromised means that the immune system is less able to fight infections. This can result in an infection that does not occur under normal conditions. This is called an opportunistic infection. An example is aspergillosis, an infection caused by a fungus. As the fungal infection is not stopped by the immune system, it spreads through the body. The fungus 'invades' the body ‐ hence we call this invasive aspergillosis. This may be lethal. Early diagnosis allows timely treatment and stops the fungus from further invading the body. </p> <p><b>What diagnostic test was studied in the review?</b> </p> <p>We wanted to find out how good 'galactomannan detection' is for diagnosing an infection of invasive aspergillosis. </p> <p>Galactomannan detection is a diagnostic procedure. It works by passing an instrument through the mouth or nose into the airways. Fluid is flushed into a part of the lung. This fluid washes fungi and other microbes from the lungs and is collected and analysed. This process is called bronchoalveolar lavage (lung‐washing), shortened to BAL. One of the things that may be in the collected BAL fluid is galactomannan, a component of the fungal cell wall. </p> <p>The result of the BAL galactomannan test is part of international criteria used to differentiate between patients who are likely to have invasive aspergillosis and patients who are less likely to have invasive aspergillosis. If multiple criteria are fulfilled (e.g. imaging tests and clinical signs and symptoms), then the patients will be treated with antifungal medication. </p> <p><b>What is the aim of this review?</b> </p> <p>The aim of this review was to determine the error rate of galactomannan testing on BAL. To this end, we searched for studies on this subject. The galactomannan test results in an 'optical density index' (ODI), not a yes or no answer. The studies differed with respect to the cut‐off value above which a result was considered positive. Most considered a result above an ODI of 0.5 or 1.0 as positive. </p> <p><b>What are the main results of this review?</b> </p> <p>Imagine a group of 1000 people with an impaired immune system where 120 (12%) have invasive aspergillosis. The results of this review indicate that in theory, if the BAL galactomannan test were to be used using an ODI of 0.5 or higher to decide which results are positive: </p> <p>‐ an estimated 273 will have a test result indicating that they probably have invasive aspergillosis, and of these 167 will be incorrectly classified as having invasive aspergillosis; and </p> <p>‐ of the 727 people with a result indicating that invasive aspergillosis is not likely to be present, 14 will be incorrectly classified as not having invasive aspergillosis. </p> <p>If a higher cut‐off value is used to determine test positivity, then more patients will have a false‐negative result and fewer patients will have a false‐positive result. </p> <p><b>How reliable are the results of the studies in this review?</b> </p> <p>In the included studies, the diagnosis of invasive aspergillosis was made by assessing all patients with international criteria (known as the reference standard). This is likely to have been a reliable method for deciding whether patients really had invasive aspergillosis. The results of the various studies differed and had small numbers of patients with invasive aspergillosis. Therefore, the numbers are an average across the studies in the review and we cannot be sure that the test will always produce these results. </p> <p><b>Who do the results of this review apply to?</b> </p> <p>The results are mainly applicable to adults who undergo intensive chemotherapy or a stem cell transplant for a form of cancer of the blood cells. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The review authors searched for and used studies published up to 9 September 2016.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012399-sec-0112" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012399-sec-0112"></div> <h3 class="title" id="CD012399-sec-0113">Implications for practice</h3> <section id="CD012399-sec-0113"> <p>Institutions can use our results to decide on the optimal cut‐off level, taking their local incidence and the clinical pathway into consideration. Although the sensitivities of the two cut‐off levels seems nearly equal, assuming a cohort of 1000 patients and a disease incidence of 12%, at a cut‐off level of 0.5, the test will on average be falsely negative in 14 patients with invasive aspergillosis (IA), and will falsely diagnose IA in 167 patients. If we use the test at a cut‐off value of 1.0, we will miss 26 patients with IA and will incorrectly diagnose IA in 62 patients (see <a href="#CD012399-sec-0088">Summary of main results</a>). </p> <p>Based on our reviews, it is not possible to determine whether the serum or bronchoalveolar lavage (BAL) galactomannan is a better test, as the diagnostic accuracies were determined in different studies with a large heterogeneity (See the <a href="#CD012399-sec-0088">Summary of main results</a>). Probably, the tests complement each other, as the other test might be positive in cases the first test is negative in. Although the diagnostic accuracy found in our review is not as high as in other reviews, it does support its prominent role in the current reference standard. </p> </section> <h3 class="title" id="CD012399-sec-0114">Implications for research</h3> <section id="CD012399-sec-0114"> <p>Research on IA is associated with a large number of methodological difficulties, as described in <a href="#CD012399-sec-0094">Applicability of findings to the review question</a>, most importantly incorporation and misclassification bias. However, the generally low‐methodological quality of the studies in our review should be improved upon. Many of the theoretically plausible forms of bias were not dealt with in the design of most studies. Although there was a significant effect of study design on the performance statistics, the current body of evidence did not allow us to determine which forms of bias did and did not play a role. </p> <p>A number of questions remains unanswered. It would be interesting if future research would focus more on clinical pathways and the relative value of other tests, such as serum galactomannan and the various polymerase chain reactions (PCR's). To this end it would be helpful if studies reported all components of the reference standard clearly. More studies on homogeneous and well‐described patient populations would also be welcome. Reporting incorporation is paramount in determining the effect and amount of incorporation. Reporting all cut‐off values would be helpful in determining the optimal cut‐off value. The quality of systematic reviews would improve if they could be performed as an individual patient data (IPD) analysis instead of a meta‐analysis. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012399-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012399-sec-0029"></div> <div class="table" id="CD012399-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>What is the diagnostic accuracy of the Platelia© <i>Aspergillus</i> ELISA for invasive aspergillosis in immunocompromised patients? </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patients/population</b>: immunocompromised patients, mostly neutropenic haematology patients. </p> <p><b>Prior testing</b>: varied. </p> <p><b>Index test</b>: the Platelia© ELISA, a sandwich ELISA for galactomannan, an <i>Aspergillus</i> antigen. </p> <p><b>Importance</b>: currently regarded as the most accurate test to diagnose invasive aspergillosis. </p> <p><b>Reference standard</b>: the EORTC/MSG criteria. </p> <p><b>Studies</b>: cohort studies reporting all EORTC‐MSG categories and of which the 2 × 2 or 4 × 2 table contained not more than one index test per participant. </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Cut‐off value</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>No. of participants</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Summary estimates (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Implications</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Quality and Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.5 ODI (12 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>229 with proven or probable IA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity: 0.88 (95% CI 0.75 to 1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>At a prevalence of 12%, 120 out of 1000 patients will develop proven or probable IA. Of these, 14 will be missed. </p> <p>Of the 880 patients with possible or no IA, 167 will have a false‐positive test result and may be unnecessarily treated. Of all 273 patients with a positive test, 106 will indeed have proven or probable IA; of all 727 negative tests, 14 will have IA after all (2%). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>All studies except one had a high risk of bias in two or more domains.</p> <p>For all studies the concerns regarding applicability were low.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>894 with possible or no IA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Specificity: 0.81 (95% CI 0.71 to 0.91)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1.0 ODI (11 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177 with proven or probable IA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity: 0.78 (95% CI 0.61 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>At a prevalence of 12%, 120 out of 1000 patients will develop proven or probable IA. Of these, 26 will be missed. </p> <p>Of the 880 patients with possible or no IA, 62 will have a false‐positive test result and may be unnecessarily treated. Of all 156 patients with a positive test, 94 will indeed have proven or probable IA; of all 844 negative tests, 26 will have IA after all (3%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>594 with possible or no IA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Specificity: 0.93 (95% CI 0.87 to 0.98)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Note, the populations and results were very heterogeneous. Therefore, interpretation and extrapolation of these results has to be performed with caution. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><b>CI:</b> confidence interval;<b>IA:</b> invasive aspergillosis; <b>ODI:</b> optical density index </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012399-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012399-sec-0030"></div> <section id="CD012399-sec-0031"> <h3 class="title" id="CD012399-sec-0031">Target condition being diagnosed</h3> <p>Although it has been suggested that the mortality rate has decreased over recent years due to more effective therapy (<a href="./references#CD012399-bbs2-0133" title="KwonJC , KimSH , ParkSH , ChoiSM , LeeDG , ChoiJH , et al. Prognosis of invasive pulmonary aspergillosis in patients with hematologic diseases in Korea. Tuberculosis and Respiratory Diseases2012;72(3):284‐92. [PUBMED: 23227068] ">Kwon 2012</a>; <a href="./references#CD012399-bbs2-0152" title="SunKS , TsaiCF , ChenSC , HuangWC . Clinical outcome and prognostic factors associated with invasive pulmonary aspergillosis: An 11‐year follow‐up report from Taiwan. PLOS One2017;12(10):e0186422. [PUBMED: 29049319] ">Sun 2017</a>), invasive aspergillosis (IA) is a life‐threatening opportunistic mycosis. Published mortality rates range from 30% to 70% (<a href="./references#CD012399-bbs2-0107" title="AisnerJ , WiernikPH , SchimpffSC . Treatment of invasive aspergillosis: relation of early diagnosis and treatment to response. Annals of Internal Medicine1977;86(5):539‐43. ">Aisner 1977</a>; <a href="./references#CD012399-bbs2-0148" title="RobenshtokE , Gafter‐GviliA , GoldbergE , WeinbergerM , YeshurunM , LeiboviciL , et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem‐cell transplantation: systematic review and meta‐analysis. Journal of Clinical Oncology2007;25(34):5471‐89. ">Robenshtok 2007</a>; <a href="./references#CD012399-bbs2-0158" title="vonEiffM , RoosN , SchultenR , HesseM , ZühlsdorfM , van deLooJ . Pulmonary aspergillosis: early diagnosis improves survival. Respiration1995;62(6):341‐7. ">von Eiff 1995</a>). Invasive aspergillosis is caused by ubiquitous spores of <i>Aspergillus</i> species, inhaled by everyone on a daily basis, which can cause invasive disease in the case of a failing immune system (<a href="./references#CD012399-bbs2-0113" title="ChotirmallSH , Al‐AlawiM , MirkovicB , LavelleG , LoganPM , GreeneCM , et al. Aspergillus‐associated airway disease, inflammation, and the innate immune response. BioMed Research International 2013 Jul 21 [Epub ahead of print]. ">Chotirmall 2013</a>). As IA mainly occurs in people with immune deficiency, the incidence varies depending on the degree of immune deficiency. In people who are highly immune deficient, such as people with acute myeloid leukaemia (AML) receiving highly intensive chemotherapy, the incidence during their treatment can exceed 5% (<a href="./references#CD012399-bbs2-0148" title="RobenshtokE , Gafter‐GviliA , GoldbergE , WeinbergerM , YeshurunM , LeiboviciL , et al. Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem‐cell transplantation: systematic review and meta‐analysis. Journal of Clinical Oncology2007;25(34):5471‐89. ">Robenshtok 2007</a>). Mainly because of the increasing application of immunosuppressive treatments, especially highly intensive chemotherapy, prolonged corticosteroid therapy and stem cell transplantation (<a href="./references#CD012399-bbs2-0128" title="KanekoT , IshigatsuboY . Increasing incidence of invasive pulmonary aspergillosis and its early diagnosis. Internal Medicine2001;40(11):1073‐4. ">Kaneko 2001</a>; <a href="./references#CD012399-bbs2-0149" title="RubioPM , SevillaJ , González‐VicentM , LassalettaA , Cuenca‐EstrellaM , Díaz MiguelA , et al. Increasing incidence of invasive aspergillosis in pediatric hematology oncology patients over the last decade: a retrospective single centre study. Journal of Pediatric Hematology/Oncology2009;31(9):642‐6. ">Rubio 2009</a>), the incidence of IA is increasing. Most often the lungs or airways (or both) are the site of infection. But IA can also occur in the nasal sinus, central nervous system, skin, gastro‐intestinal tract, the deep structures of the eye, and prosthetic heart valves; or may give rise to a disseminated infection. </p> </section> <section id="CD012399-sec-0032"> <h3 class="title" id="CD012399-sec-0032">Index test(s)</h3> <p>Galactomannan is a cell wall component of <i>Aspergillus</i> species and <i>Penicillium</i> species <i>(</i><a href="./references#CD012399-bbs2-0135" title="LatgéJP , KobayashiH , DebeaupuisJP , DiaquinM , SarfatiJ , WieruszeskiJM , et al. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infection and Immunity1994;62(12):5424‐33. ">Latgé 1994</a>). It is excreted by the fungus during the growth phase. It is suggested that the level of galactomannan antigenaemia is proportional to the fungal tissue load and has a prognostic value (<a href="./references#CD012399-bbs2-0132" title="KooS , BryarJM , BadenLR , MartyFM . Prognostic features of galactomannan antigenemia in galactomannan‐positive invasive aspergillosis. Journal of Clinical Microbiology2010;48(4):1255‐60. ">Koo 2010</a>). </p> <p>Currently, galactomannan detection in bronchoalveolar lavage (BAL), usually performed as a result of a chest computerised tomography (CT) scan consistent with IA, is considered the most accurate test to diagnose or exclude IA. A meta‐analysis in 2010 reported a sensitivity of 90% and a specificity of 94% (<a href="./references#CD012399-bbs2-0118" title="GuoYL , ChenYQ , WangK , QinSM , WuC , KongJL . Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest2010;138(4):817‐24. ">Guo 2010</a>). </p> <p>Currently, there is one commercially available assay for the detection of galactomannan in BAL, the Platelia™ sandwich enzyme‐linked immunosorbent assay (ELISA) test. It can also be applied on serum, cerebrospinal fluid, pleural fluid and urine (<a href="./references#CD012399-bbs2-0108" title="AsciogluS , dePauwBE , DonnellyJP , ColletteL . Reliability of clinical research on invasive fungal infections: a systematic review of the literature. Medical Mycology2001;39(1):35‐40. ">Ascioglu 2001</a>; <a href="./references#CD012399-bbs2-0122" title="HopeWW , WalshTJ , DenningDW . Laboratory diagnosis of invasive aspergillosis. Lancet2005;5(10):609‐22. ">Hope 2005</a>). Results of the ELISA are given as an optical density index (ODI), which is the ratio of the optical density of (usually) 1 ng/mL galactomannan versus the optical density of the sample. In order to enhance the specificity of the test, the Food and Drug Aministration (FDA) changed the recommended cut‐off for positivity in the USA from an ODI of 0.5 to 1.0 (<a href="./references#CD012399-bbs2-0156" title="U.S. Food and Drug Administration/Center for Drug Evaluation and Research. Detection of galactomannan in serum by platelia aspergillus enzyme‐linked immunosorbent assay (BioRad Laboratories and Sanofi Diagnostics). www.fda.gov/downloads/Drugs/.../Guidances/UCM420236.pdf (accessed prior to 23 May 2018). ">U. S. Food and Drug Administration 2011</a>). </p> </section> <section id="CD012399-sec-0033"> <h3 class="title" id="CD012399-sec-0033">Clinical pathway</h3> <section id="CD012399-sec-0034"> <h4 class="title">Indication</h4> <p>There is no generally accepted indication for galactomannan testing in BAL, and no generally accepted consequence of a specific test result. </p> <p>Clinical signs and symptoms of IA are non‐specific at an early stage. Establishing a diagnosis at an early stage of infection improves the chances of survival through subsequent earlier treatment (<a href="./references#CD012399-bbs2-0157" title="UptonA , KirbyKA , CarpenterP , BoeckhM , MarrKA . Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clinical Infectious Diseases2007;44(4):531‐40. ">Upton 2007</a>; <a href="./references#CD012399-bbs2-0158" title="vonEiffM , RoosN , SchultenR , HesseM , ZühlsdorfM , van deLooJ . Pulmonary aspergillosis: early diagnosis improves survival. Respiration1995;62(6):341‐7. ">von Eiff 1995</a>). A definitive diagnosis can be made by two means. By autopsy, or "by a positive culture of <i>A.fumigatus</i> in a specimen obtained with a sterile procedure from a normally sterile site that is clinically or radiologically abnormal and consistent with an infectious disease process (excluding bronchoalveolar lavage fluid, a cranial sinus cavity specimen, and urine)" (<a href="./references#CD012399-bbs2-0116" title="DePauwB , WalshTJ , DonnellyJP , StevensDA , EdwardsJE , CalandraT , et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases2008;46(12):1813‐21. ">De Pauw 2008</a>). However, the person's clinical condition (frequently including thrombocytopenia (reduced numbers of platelets) because of preceding chemotherapy) often prohibits invasive techniques. Cultures are frequently false‐negative. In fact, definitive diagnoses of IA are rare. In clinical practice one usually has to work with presumed diagnoses with a varying level of suspicion. In 2008, a committee consisting of the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer (EORTC), the Mycoses Study Group (MSG) and the National Institute of Allergy and Infectious Diseases proposed to grade the diagnosis of IA with three levels of probability: 'proven', 'probable' and 'possible' IA (see <a href="#CD012399-tbl-0002">Table 1</a>; <a href="./references#CD012399-bbs2-0116" title="DePauwB , WalshTJ , DonnellyJP , StevensDA , EdwardsJE , CalandraT , et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases2008;46(12):1813‐21. ">De Pauw 2008</a>). There is also a fourth category of people without IA. The divisions are based on host factor criteria (a set of risk factors, which are designed to almost preclude IA if all are absent, an example being chemotherapy‐induced prolonged neutropenia, clinical criteria (specific clinical and radiological signs such as a chest CT consistent with IA), and microbiological criteria (for example, <i>Aspergillus</i> species cultured from BAL). This consensus was a revision of a consensus reached in 2002, see <a href="#CD012399-tbl-0003">Table 2</a>. A positive galactomannan test, whichever fluid it is applied on, is a microbiological criterion in both versions. Clinical studies have shown that these criteria do not match autopsy results perfectly. This holds especially true for the 'possible' category. For clinical trials investigating the effect of treatment of IA, it is recommended that only people in 'proven' or 'probable' categories are considered to have IA (<a href="./references#CD012399-bbs2-0112" title="BorlenghiE , CattaneoC , CapucciMA , PanA , QuaresminiG , FrancoF , et al. Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates. Annals of Hematology2007;86(3):205‐10. ">Borlenghi 2007</a>; <a href="./references#CD012399-bbs2-0151" title="SubiràM , MartinoR , RoviraM , VazquezL , SerranoD , De LaCámaraR . Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy‐confirmed invasive aspergillosis. Annals of Hematology2003;82(2):80‐2. ">Subirà 2003</a>). </p> <div class="table" id="CD012399-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">EORTC/MSG criteria, 2008 version</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Host criterion</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical criterion</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Microbiological criterion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Possible IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Probable IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>IA:</b> invasive aspergillosis </p> </div> </div> <div class="table" id="CD012399-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">EORTC/MSG criteria, 2002 version</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Host criterion</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical criterion</b> </p> <p><b>(1 major or 2 minor)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Microbiological criterion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Possible IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Either one of these is required</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Probable IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>IA:</b> invasive aspergillosis </p> </div> </div> <p>Because of its invasiveness, the test is usually employed in the clinical pathway of <b>a person at risk of IA, who is also suspected of having IA based on clinical and/or radiological grounds</b>. The test is rarely used as a screening test in asymptomatic persons, whether they are at risk or not. In the setting of chemotherapy‐induced prolonged neutropenia, the host factor that causes the majority of cases of IA, a full work‐up is performed in most centres as a result of a number of indications, including most notably: fever not responsive to broad spectrum antibiotics, a positive galactomannan test on serum, or hyphae or moulds found in a respiratory specimen. This work‐up will include a chest CT. In case it is consistent with IA, a BAL and the index test are performed, if the clinical condition permits. </p> </section> <section id="CD012399-sec-0035"> <h4 class="title">Clinical consequence</h4> <p>The consequences of a positive or negative index test vary among hospitals and will usually depend on the EORTC/MSG classification after the full diagnostic work‐up. </p> <p>Despite a negative index test, a person can still be classified as having 'probable' IA (based on another microbiological criterion) or as having 'proven' IA. Also, he or she can still be classified as having 'possible' IA due to a clinical criterion. As BAL is usually performed because of a chest CT consistent with IA (a clinical criterion) in a patient at risk of IA (a host criterion), a classification of 'no' IA will not occur very frequently. For the same reason, in case of a positive index test a person will often be classified as having 'probable' IA. </p> <p>Someone with 'probable' IA will usually be considered to have IA and treated accordingly. Although it is very well possible that a person classified as having 'possible' IA in fact has 'no' IA, the likelihood rises, and in light of the high mortality many clinicians will also prefer to treat such a person for IA. So it could seem the test has no clinical consequence. However, the duration of therapy with expensive and toxic antimycotics is usually longer in probable aspergillosis than in possible aspergillosis. It can also influence the choice of antimycotic, as the odds of an invasive mould infection other than aspergillosis decrease with a positive test result. Moreover, in case of side effects it is more likely a clinician would continue therapy in a patient with probable aspergillosis. Moreover, further immunosuppressive treatment such as chemotherapy or stem cell transplantation, which is often essential in curing a patient, is contra‐indicated in people with IA. </p> </section> <section id="CD012399-sec-0036"> <h4 class="title">Risk factors</h4> <p>There are other risk factors for IA besides chemotherapy‐induced prolonged neutropenia that increasingly warrant the index test. Most notable are: </p> <p> <ul id="CD012399-list-0001"> <li> <p>allogeneic stem cell transplantation and/or graft‐versus‐host disease;</p> </li> <li> <p>intensive care unit (ICU) admittance;</p> </li> <li> <p>chronic pulmonary disease, such as chronic obstructive pulmonary disease (COPD) and bronchiectasis; </p> </li> <li> <p>acquired immune deficiency syndrome (AIDS);</p> </li> <li> <p>immunosuppressive drugs, such as tumour necrosis factor‐alpha (TNF‐a) inhibitors;</p> </li> <li> <p>long‐term steroid use;</p> </li> <li> <p>inherited severe immunodeficiency;</p> </li> <li> <p>decompensated cirrhosis; and</p> </li> <li> <p>influenza.</p> </li> </ul> </p> <p>The 2002 version of the EORTC/MSG criteria also contained the following host criteria:</p> <p> <ul id="CD012399-list-0002"> <li> <p>fever refractory to broad‐spectrum antibacterial treatment in high‐risk patients; and </p> </li> <li> <p>'proven' or 'probable' invasive fungal infection during previous episode of neutropenia.</p> </li> </ul> </p> </section> <section id="CD012399-sec-0037"> <h4 class="title">Alternative test(s)</h4> <p>There are many alternative tests, such as direct microscopy, histopathological examination, microbiological culture, and less frequently performed: beta‐D‐glucan testing and various polymerase chain reactions (PCRs). These can be performed on a number of specimens, such as respiratory samples, serum, BAL or tissue samples. The galactomannan ELISA can also be applied on other fluids, such as cerebrospinal fluid (CSF), pleural fluid and urine. None has a reported sensitivity or specificity comparable with the index test (<a href="./references#CD012399-bbs2-0115" title="Cuenca‐EstrellaM , BassettiM , Lass‐FlörlC , RácilZ , RichardsonM , RogersTR . Detection and investigation of invasive mould disease. Journal of Antimicrobial Chemotherapy2011;66 Suppl 1:i15‐24. ">Cuenca‐Estrella 2011</a>; <a href="./references#CD012399-bbs2-0118" title="GuoYL , ChenYQ , WangK , QinSM , WuC , KongJL . Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest2010;138(4):817‐24. ">Guo 2010</a>; <a href="./references#CD012399-bbs2-0130" title="KarageorgopoulosDE , VouloumanouEK , NtzioraF , MichalopoulosA , RafailidisPI , FalagasME . β‐D‐glucan assay for the diagnosis of invasive fungal infections: a meta‐analysis. Clinical Infectious Diseases2011;52(6):750‐70. ">Karageorgopoulos 2011</a>; <a href="./references#CD012399-bbs2-0134" title="LamothF , CrucianiM , MengoliC , CastagnolaE , LortholaryO , RichardsonM , et al. β‐Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta‐analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL‐3). Clinical Infectious Diseases2012;54(5):633‐43. ">Lamoth 2012</a>; <a href="./references#CD012399-bbs2-0144" title="PickeringJW , SantHW , BowlesCA , RobertsWL , WoodsGL . Evaluation of a (1‐&gt;3)‐beta‐D‐glucan assay for diagnosis of invasive fungal infections. Journal of Clinical Microbiology2005;43(12):5957‐62. ">Pickering 2005</a>; <a href="./references#CD012399-bbs2-0163" title="ZouM , TangL , ZhaoS , ZhaoZ , ChenL , ChenP , et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLOS One2012;7(8):e43347. [PUBMED: 22905261] ">Zou 2012</a>). There are published Cochrane Reviews on the index test performed on serum (<a href="./references#CD012399-bbs2-0136" title="LeeflangMM , Debets‐OssenkoppYJ , WangJ , VisserCE , ScholtenRJ , HooftL , et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD007394.pub2] ">Leeflang 2015</a>), and on PCR blood tests (<a href="./references#CD012399-bbs2-0114" title="CrucianiM , MengoliC , LoefflerJ , DonnellyP , BarnesR , JonesBL , et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD009551.pub2] ">Cruciani 2015</a>). </p> </section> </section> <section id="CD012399-sec-0038"> <h3 class="title" id="CD012399-sec-0038">Rationale</h3> <p>There are already a number of meta‐analyses on the diagnostic value of BAL galactomannan. However, the fact that the index test plays an important role in the set of criteria that forms the reference standard confers a difficulty in interpreting such analyses. Our meta‐analysis adds an evaluation of this and other sources of heterogeneity to the previous meta‐analyses. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012399-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012399-sec-0039"></div> <p>To assess the diagnostic accuracy of galactomannan detection in bronchoalveolar lavage (BAL) for the diagnosis of invasive aspergillosis (IA) in people who are immunocompromised, at different cut‐off values for test positivity, in accordance with the <a href="http://methods.cochrane.org/sdt/handbook-dta-reviews" target="_blank">Cochrane Diagnostic Test Accuracy Handbook</a>. </p> <section id="CD012399-sec-0040"> <h3 class="title" id="CD012399-sec-0040">Secondary objectives</h3> <p>Our secondary objective was to study several possible sources of heterogeneity:</p> <p> <ul id="CD012399-list-0003"> <li> <p>the effect of cut‐off value,</p> </li> <li> <p>the effect of incorporation bias (the incorporation of the index test in the reference standard), </p> </li> <li> <p>the effect of pre‐selection based on a positive serum galactomannan test,</p> </li> <li> <p>the effect of the revision of the reference standard,</p> </li> <li> <p>the effect of a protocol that defines the exact and explicit indication of the index test, </p> </li> <li> <p>study design,</p> </li> <li> <p>the effect of sponsoring of the study by the manufacturer of the commercially available galactomannan test, </p> </li> <li> <p>clinical subgroups.</p> </li> </ul> </p> <p>See also '<a href="#CD012399-sec-0056">Investigations of heterogeneity</a>'. </p> </section> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012399-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012399-sec-0041"></div> <section id="CD012399-sec-0042"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012399-sec-0043"> <h4 class="title">Types of studies</h4> <p>Eligible studies were those that assessed the diagnostic accuracy of galactomannan detection in bronchoalveolar lavage (BAL). The galactomannan enzyme‐linked immunosorbent assay (ELISA) could be assessed alone or in comparison with (an)other test(s). </p> </section> <section id="CD012399-sec-0044"> <h4 class="title">Participants</h4> <p>Immunocompromised participants who have been tested to diagnose, exclude or screen for invasive aspergillosis (IA) using galactomannan detection in BAL. We defined immunocompromised as the presence of one of the EORTC/MSG host criteria, either of the 2002 or 2008 version. The current version of the EORTC/MSG criteria was anticipated to be updated with two extra host criteria: chronic airway abnormalities and decompensated cirrhosis. We also included studies on participants with immune deficiencies as per the anticipated version of the EORTC/MSG criteria. If in more than 10% of the participants a EORTC/MSG host criterion was not present, a study was excluded. </p> </section> <section id="CD012399-sec-0045"> <h4 class="title">Index tests</h4> <p>The commercially available galactomannan sandwich ELISA (Platelia™) performed on BAL was the test under evaluation. Studies addressing detection in serum and other body fluids were excluded. </p> </section> <section id="CD012399-sec-0046"> <h4 class="title">Target conditions</h4> <p>The target condition of this review was invasive pulmonary aspergillosis.</p> </section> <section id="CD012399-sec-0047"> <h4 class="title">Reference standards</h4> <p>The following reference standards were used to define the target condition:</p> <p> <ul id="CD012399-list-0004"> <li> <p>autopsy specimens, with histopathological evidence of aspergillosis and a positive culture; </p> </li> <li> <p>the EORTC/MSG criteria, see <a href="#CD012399-tbl-0004">Table 3</a> and <a href="#CD012399-tbl-0005">Table 4</a> for the criteria in full detail. </p> </li> </ul> </p> <div class="table" id="CD012399-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Full EORTC/MSG criteria, 2008 version</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Possible / probable invasive aspergillosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Host factors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0005"> <li> <p>Recent history of neutropenia (&lt; 0.5 x 10 9 neutrophils/L [&lt; 500 neutrophils/mm<sup>3</sup>] for &gt; 10 days) temporally related to the onset of fungal disease. </p> </li> <li> <p>Receipt of an allogeneic stem cell transplant</p> </li> <li> <p>Prolonged use of corticosteroids (excluding among patients with allergic bronchopulmonary aspergillosis) at a mean minimum dose of 0.3 mg/kg/day of prednisone equivalent for &gt; 3 weeks </p> </li> <li> <p>Treatment with other recognized T cell immunosuppressants, such as cyclosporine, TNF‐a blockers, specific monoclonal antibodies (such as alemtuzumab), or nucleoside analogues during the past 90 days </p> </li> <li> <p>Inherited severe immunodeficiency (such as chronic granulomatous disease or severe combined immunodeficiency </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0006"> <li> <p>Lower respiratory tract fungal disease (every reasonable attempt should be made to exclude an alternative etiology), with the presence of 1 of the following 3 signs on CT </p> <ul id="CD012399-list-0007"> <li> <p>Dense, well‐circumscribed lesions(s) with or without a halo sign</p> </li> <li> <p>Air‐crescent sign</p> </li> <li> <p>Cavity</p> </li> </ul> </li> <li> <p>Tracheobronchitis: tracheobronchial ulceration, nodule, pseudomembrane, plaque, or eschar seen on bronchoscopic analysis </p> </li> <li> <p>Sinonasal infection: Imaging showing sinusitis plus at least 1 of the following 3 signs: </p> <ul id="CD012399-list-0008"> <li> <p>Acute localized pain (including pain radiating to the eye)</p> </li> <li> <p>Nasal ulcer with black eschar</p> </li> <li> <p>Extension from the paranasal sinus across bony barriers, including into the orbit</p> </li> </ul> </li> <li> <p>CNS infection: 1 of the following 2 signs:</p> <ul id="CD012399-list-0009"> <li> <p>Focal lesions on imaging</p> </li> <li> <p>Meningeal enhancement on MRI</p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mycological criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Direct test (cytology, direct microscopy, or culture) showing mold in sputum, bronchoalveolar lavage fluid, bronchial brush, or sinus aspirate samples, indicated by 1 of the following: </p> <p> <ul id="CD012399-list-0010"> <li> <p>Presence of fungal elements indicating a mold</p> </li> <li> <p>Recovery by culture of a mold (e.g., <i>Aspergillus</i> , <i>Fusarium, Zygomycetes,</i> or<i>Scedosporium</i> species) </p> </li> </ul> </p> <p>Indirect tests (detection of antigen or cell‐wall constituents)</p> <p> <ul id="CD012399-list-0011"> <li> <p>Aspergillosis: Galactomannan antigen detected in plasma, serum, bronchoalveolar lavage fluid, or CSF </p> </li> <li> <p>Invasive fungal disease other than cryptococcosis and zygomycoses: b‐d‐glucan detected in serum </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Proven aspergillosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Criteria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0012"> <li> <p>Histopathologic, cytopathologic, or direct microscopic examination of a specimen obtained by needle aspiration or biopsy in which hyphae or melanized yeast‐like forms are seen accompanied by evidence of associated tissue damage; or, </p> </li> <li> <p>Recovery of a mold or “black yeast” by culture of a specimen obtained by a sterile procedure from a normally sterile and clinically or radiologically abnormal site consistent with an infectious disease process, excluding bronchoalveolar lavage fluid, a cranial sinus cavity specimen, and urine. </p> </li> </ul> </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD012399-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Full EORTC/MSG criteria, 2002 version</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Possible / Probable invasive aspergillosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Host factors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0013"> <li> <p>Neutropenia (&lt; 500 neutrophils/mm<sup>3</sup> for &gt; 10 days) </p> </li> <li> <p>Persistent fever for &gt; 96 h refractory to appropriate broad‐spectrum antibacterial treatment in high‐risk patients </p> </li> <li> <p>Body temperature either &gt; 38°C or &lt; 36°C and any of the following predisposing conditions: prolonged neutropenia (&gt; 10 days) in previous 60 days, recent or current use of significant immunosuppressive agents in previous 30 days, proven or probable invasive fungal infection during previous episode of neutropenia, or coexistence of symptomatic AIDS </p> </li> <li> <p>Signs and symptoms indicating graft‐versus‐host disease, particularly severe (grade ≥ 2) or chronic extensive disease </p> </li> <li> <p>Prolonged (&gt; 3 weeks) use of corticosteroids in previous 60 days</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Must be related to site of microbiological criteria and temporally related to current episode </p> <p> <ul id="CD012399-list-0014"> <li> <p>Lower respiratory tract infection</p> <ul id="CD012399-list-0015"> <li> <p>Major: Any of the following new infiltrates on CT imaging: halo sign, air‐crescent sign, or cavity within area of consolidation, in absence of infection by organisms that may lead to similar radiological findings including cavitation, such as Mycobacterium, Legionella, and Nocardia species. </p> </li> <li> <p>Minor: Symptoms of lower respiratory tract infection (cough, chest pain, haemoptysis, dyspnoea); physical finding of pleural rub; any new infiltrate not fulfilling major criterion; pleural effusion </p> </li> </ul> </li> <li> <p>Sinonasal infection</p> <ul id="CD012399-list-0016"> <li> <p>Major: Suggestive radiological evidence of invasive infection in sinuses (i.e., erosion of sinus walls or extension of infection to neighbouring structures, extensive skull base destruction) </p> </li> <li> <p>Minor: Upper respiratory symptoms (e.g. nasal discharge, stuffiness); nose ulceration or eschar of nasal mucosa or epistaxis; periorbital swelling; maxillary tenderness; black necrotic lesions or perforation of hard palate </p> </li> </ul> </li> <li> <p>CNS infection</p> <ul id="CD012399-list-0017"> <li> <p>Major: Radiological evidence suggesting CNS infection (e.g. mastoiditis or other parameningeal foci, extradural empyema, intraparenchymal brain or spinal cord mass lesion) </p> </li> <li> <p>Minor: Focal neurological symptoms and signs (including focal seizures, hemiparesis, and cranial nerve palsies); mental changes; meningeal irritation findings; abnormalities in CSF biochemistry and cell count (provided that CSF is negative for other pathogens by culture or microscopy and negative for malignant cell </p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Microbiological criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0018"> <li> <p>Positive result of culture for mold (including <i>Aspergillus</i> , <i>Fusarium</i> , or <i>Scedosporium</i> species or a <i>Zygomycetes</i> ) or <i>Cryptococcus neoformans</i> or an endemic fungal pathogen from sputum or bronchoalveolar lavage fluid samples </p> </li> <li> <p>Positive result of culture or findings of cytologic/direct microscopic evaluation for mold from sinus aspirate specimen </p> </li> <li> <p>Positive findings of cytologic/direct microscopic evaluation for mold or Cryptococcus species from sputum or bronchoalveolar lavage fluid samples </p> </li> <li> <p>Positive result for <i>Aspergillus</i> antigen in specimens of bronchoalveolar lavage fluid, CSF, or ≥ 2 blood samples </p> </li> <li> <p>Positive result for cryptococcal antigen in blood sample</p> </li> <li> <p>Positive findings of cytologic or direct microscopic examination for fungal elements in sterile body fluid samples (e.g. Cryptococcus species in CSF) </p> </li> <li> <p>Positive result for Histoplasma capsulatum antigen in blood, urine, or CSF specimens</p> </li> <li> <p>Two positive results of culture of urine samples for yeasts in absence of urinary catheter </p> </li> <li> <p>Candida casts in urine in absence of urinary catheter</p> </li> <li> <p>Positive result of blood culture for Candida species</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Proven aspergillosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criterion</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Histopathologic or cytopathologic examination showing hyphae from needle aspiration or biopsy specimen with evidence of associated tissue damage (either microscopically or unequivocally by imaging); or positive culture result for a sample obtained by sterile procedure from normally sterile and clinically or radiologically abnormal site consistent with infection, excluding urine and mucous membranes. </p> </td> </tr> </tbody> </table> </div> <p>The results within each possible EORTC classification (‘no’, ‘possible’, ‘probable’ and ‘proven’ IA) had to be reported, or the results within the combined groups ‘no/possible’ and ‘probable/proven’ IA. </p> </section> </section> <section id="CD012399-sec-0048"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD012399-sec-0049"> <h4 class="title">Electronic searches</h4> <p>We searched Embase and MEDLINE through Ovid for aspergillosis and galactomannan as Medical Heading and text word, see <a href="./appendices#CD012399-sec-0118">Appendix 1</a> for the exact terms. The appendix also lists the terms that were used to search the Web of Science Core Collection (1970 to date of search). The version of MEDLINE we searched was Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) 1946 to 9th September 2016. We searched the literature from 2000 onwards, as the reference standard was published in 2002. </p> <p>We conducted the searches on 9 September 2016. All studies published after the date of the initial search will be included in the next update of the systematic review. The search for the update is planned for September 2021. </p> </section> <section id="CD012399-sec-0050"> <h4 class="title">Searching other resources</h4> <p>To identify additional published studies, we:</p> <p> <ul id="CD012399-list-0019"> <li> <p>entered the included studies into PubMed and then used the Related Articles feature;</p> </li> <li> <p>searched the Science Citation Index to identify articles that cite the included studies;</p> </li> <li> <p>checked the reference lists of all included studies.</p> </li> </ul> </p> </section> </section> <section id="CD012399-sec-0051"> <h3 class="title" id="CD012399-sec-0051">Data collection and analysis</h3> <section id="CD012399-sec-0052"> <h4 class="title">Selection of studies</h4> <p>The first selection, based on title and abstract, was performed by two review authors (KdH, MG). We excluded articles that were judged to be highly unlikely to report the test performance of galactomannan detection in bronchoalveolar lavage, such as animal studies, plant studies, or studies on fungi other than <i>Aspergillus</i> species. Afterwards, we located the full paper of each potentially eligible article. Two of four review authors (KdH, MG, CV, ML) independently assessed all eligible articles for inclusion. We resolved disagreement by discussion. We included articles when we could not resolve disagreement. </p> <p>We excluded studies:</p> <p> <ul id="CD012399-list-0020"> <li> <p>that were not published in an English peer‐reviewed journal (we will include these in the first update of this review); </p> </li> <li> <p>that did not enrol patients consecutively;</p> </li> <li> <p>that were case‐control studies;</p> </li> <li> <p>of which the 2 × 2 or 4 × 2 table contained more than one index test per participant;</p> </li> <li> <p>that (partially) contained the data of another study/publication;</p> </li> <li> <p>that did not report all index test results of the studied cohort, e.g. a study that does not report the results of the 'possible' IA and/or 'no' IA group; </p> </li> <li> <p>that contained an ostensible calculation error in the 2 × 2 or 4 × 2 table.</p> </li> </ul> </p> <p>We contacted the study authors for more information before excluding studies on the last two grounds. </p> </section> <section id="CD012399-sec-0053"> <h4 class="title">Data extraction and management</h4> <p>The following data were extracted:</p> <p> <ul id="CD012399-list-0021"> <li> <p>author, year of publication and journal;</p> </li> <li> <p>our application of the QUADAS‐2 tool, see <a href="./appendices#CD012399-sec-0122">Appendix 2</a>, for which a data‐extraction form and background document had been designed; </p> </li> <li> <p>the data for a 4 × 2 or 2 × 2 table.</p> </li> </ul> </p> <p>The data‐extraction form was accompanied by a background document that stated how each item on the form was to be interpreted. We standardised the form and piloted it on two studies. Four review authors (KdH, MG, CV, ML) extracted data and assessed quality. One review author (KdH) has a haematological background, one (MG) a medical background, one (CV) a microbiological background, and one (ML) a methodological background. The articles were randomly allocated to a pair of review authors. Disagreements were resolved by discussion. </p> </section> <section id="CD012399-sec-0054"> <h4 class="title">Assessment of methodological quality</h4> <p>Study quality was assessed using the QUADAS‐2 data‐extraction form. For four domains a number of pre‐defined signalling questions were scored as 'yes', 'no' or 'unclear', or had to be answered with free text. Then, per domain the risk of bias was judged to be either 'low', 'high' or 'unclear', based on the answers to these signalling questions (<a href="./references#CD012399-bbs2-0162" title="WhitingPF , RutjesAW , WestwoodME , MallettS , DeeksJJ , ReitsmaJB , et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine2011;155(8):529‐36. ">Whiting 2011</a>). Results are presented in text, in a graph and in a table. We did not calculate a summary score estimating the overall quality of an article since the interpretation of such summary scores is problematic and potentially misleading (<a href="./references#CD012399-bbs2-0127" title="JüniP , WitschiA , BlochR , EggerM . The hazards of scoring the quality of clinical trials for meta‐analysis. JAMA1999;282(11):1054‐60. ">Jüni 1999</a>; <a href="./references#CD012399-bbs2-0161" title="WhitingP , HarbordR , KleijnenJ . No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Medical Research Methodology2005;5:19. ">Whiting 2005</a>). We did not assess the concern about applicability for the patient domain, as we did not have a specific population of interest in mind and expected to find studies with a wide range of patients. After all, one cannot say that in a study on lung transplant patients (in which, quite understandably, the diagnostic accuracy is very different from the diagnostic accuracy which is found in a study on allogeneic stem cell transplantation patients) there is a problem with applicability. However, the results of the study are not applicable to patients undergoing allogeneic stem cell transplantation. Instead, we chose to carefully document the type of participants. For the index test and reference standard domains, we classified all studies to have a low applicability concern because our inclusion criteria stipulated that we only include studies that used the galactomannan ELISA performed on BAL as the index test and the EORTC/MSG criteria as reference standard. Therefore no studies that were subject to applicability concerns on these two domains were included. </p> </section> <section id="CD012399-sec-0055"> <h4 class="title">Statistical analysis and data synthesis</h4> <p>The EORTC/MSG criteria were our reference standards. They classify participants into one of four groups: 'proven' IA, 'probable' IA, 'possible' IA and 'no' IA. This results in a two‐by‐four table: a positive or negative galactomannan test result versus each of the four reference groups. To calculate test accuracy, we defined the 'proven' and 'probable' participants as having IA; and we defined 'no' IA and 'possible' IA participants as not having IA, in order to construct two‐by‐two tables. Other classifications of participants having and not having IA were assessed in a sensitivity analysis. </p> <p>We calculated the sensitivity and specificity for each study per reported cut‐off value. We also plotted the individual study results in forest plots and the receiver operating characteristic (ROC) space. </p> <p>We used a bivariate random‐effects approach for a meta‐analysis of the pairs of sensitivity and specificity (<a href="./references#CD012399-bbs2-0145" title="ReitsmaJB , GlasAS , RutjesAW , ScholtenRJ , BossuytPM , ZwindermanAH . Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of Clinical Epidemiology2005;58(10):982‐90. ">Reitsma 2005</a>; <a href="http://methods.cochrane.org/sdt/handbook-dta-reviews" target="_blank">Cochrane Diagnostic Test Accuracy Handbook</a>). Covariates were incorporated in the bivariate model to examine the effect of potential sources of bias and variation across subgroups of studies. Due to the bivariate nature of the model, effects of covariates on sensitivity and specificity could be modelled separately. </p> <p>For the meta‐analysis we used the two‐by‐two table of one cut‐off value per study. Otherwise, the more cut‐off values a study reports, the larger its impact on the outcome of the analysis becomes. We chose the thresholds of 0.5 or 1.0, if reported, because these are the positivity thresholds currently and formerly recommended. We expected most studies in our analysis to report either an optical density index (ODI) of 1.0 or 0.5. If both were reported, we selected one at random. As the random inclusion could have had an effect on the outcome of the meta‐analysis, we performed a sensitivity analysis by including the two‐by‐two tables of an ODI of 0.5 <b>as well as</b> an ODI of 1.0, if both were reported. </p> <p>All analyses were performed in SAS, version 9.4, using Proc NLMIXED.</p> </section> <section id="CD012399-sec-0056"> <h4 class="title">Investigations of heterogeneity</h4> <p>Heterogeneity was investigated first through visual examination of the forest plots and the raw ROC plot of all data in the review, at all cut‐off values. Then, the potential sources of heterogeneity were included in the meta‐analysis as a covariate. We assumed no interaction between the sources of heterogeneity. We addressed the following possible sources. </p> <section id="CD012399-sec-0057"> <h5 class="title">a. Effect of cut‐off value</h5> <p>A main source of heterogeneity in diagnostic test accuracy reviews are the differences in the applied cut‐off values between studies. We first investigated what the influence of these cut‐off values was on the sensitivity and specificity by including the cut‐off value as a covariate in the meta‐analysis. </p> </section> <section id="CD012399-sec-0058"> <h5 class="title">b. Effect of incorporation bias (incorporation of the index test in the reference standard) </h5> <p>A positive galactomannan test is incorporated in the EORTC/MSG criteria. Studies that do not exclude this criterion from the reference standard might overestimate the diagnostic accuracy of the index test. Vice versa, a study that does exclude this criterion from the reference standard might underestimate the diagnostic accuracy. We studied the effect of incorporation of the BAL and serum galactomannan test, as these are dependent tests. </p> </section> <section id="CD012399-sec-0059"> <h5 class="title">c. Effect of pre‐selection based on a positive serum galactomannan test</h5> <p>The indication for the index test in a study, and if applicable the clinical pathway in which it is embedded, are major determinants of the accuracy of the index test. We expected many studies not to contain a clinical pathway and the triggers to vary greatly, or even to be documented unclearly. We extracted as much detail as possible on the indication for the index test, the associated clinical pathway and the tests performed prior to the index test, but we expected that analysis of heterogeneity on this form of bias would not be feasible. </p> <p>We did expect all studies to report whether a positive serum galactomannan could have been the indication for the index test. We studied the effect of this possibility. </p> </section> <section id="CD012399-sec-0060"> <h5 class="title">d. Effect of the reference standard</h5> <p>The criteria of the EORTC/MSG were our reference standard. We studied the effect of the 2008 update of these criteria. </p> </section> <section id="CD012399-sec-0061"> <h5 class="title">e. Effect of a protocol that defines the exact and explicit indication of the index test </h5> <p>We studied the effect of the presence of a formal indication for performing the index test in the study protocol. </p> </section> <section id="CD012399-sec-0062"> <h5 class="title">f. Study design</h5> <p>We defined a study that uses a data set not created for the purpose of a research question as retrospective. We defined a study that includes patients consecutively after the formulation of a research question as prospective. We studied the heterogeneity as an effect of study design. </p> </section> <section id="CD012399-sec-0063"> <h5 class="title">g. Effect of sponsoring</h5> <p>We studied the effect of sponsoring of the study by the manufacturer of the commercially available galactomannan test. </p> </section> <section id="CD012399-sec-0064"> <h5 class="title">h. Clinical subgroups</h5> <p>We explored the possible influence of clinical subgroups by including the following additional covariates in the meta‐analysis. </p> <p> <ul id="CD012399-list-0022"> <li> <p>children versus adult participants — we assumed a cut‐off at age 16 to 18 to differentiate between children and adults; </p> </li> <li> <p>participants with neutropenia versus all other participant groups; we also performed a subgroup analysis comparing groups based on the different host criteria; </p> </li> <li> <p>routine use of anti‐mould prophylaxis in a study (yes versus no);</p> </li> <li> <p>the department(s) where the patients were recruited.</p> </li> </ul> </p> </section> </section> <section id="CD012399-sec-0065"> <h4 class="title">Sensitivity analyses</h4> <section id="CD012399-sec-0066"> <h5 class="title">a. Methodological quality</h5> <p>To assess whether methodological quality influenced the results, we performed a sensitivity analysis by leaving out the studies with a relatively low methodological quality. </p> </section> <section id="CD012399-sec-0067"> <h5 class="title">b. Effect of positive and negative reference standard definition</h5> <p>Although it is uncertain whether a participant with 'possible' IA has invasive aspergillosis or not, we considered a participant with 'possible' IA as having no invasive aspergillosis and we combined these participants with those with 'no' IA when calculating sensitivity and specificity. We acknowledge the methodological difficulty of this choice and therefore studied its effect in a sensitivity analysis. We also examined the effect of ignoring 'possible' IA ('proven' and 'probable' versus 'no' IA). </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012399-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012399-sec-0068"></div> <section id="CD012399-sec-0069"> <h3 class="title" id="CD012399-sec-0069">Results of the search</h3> <p>Our search was performed on 9 September 2016 and resulted in 5844 hits. The initial screening, excluding the studies that were judged beyond any doubt not to contain original data on the diagnostic value of bronchoalveolar lavage (BAL) galactomannan in diagnosing invasive aspergillosis (IA), or that were not published in a peer‐reviewed journal, resulted in 103 eligible reports of which the full text was retrieved (<a href="#CD012399-fig-0001">Figure 1</a>). We excluded two non‐English reports from the assessment which were studies eligible for inclusion. We will assess the translated versions at the first update of this review. </p> <div class="figure" id="CD012399-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD012399-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>We sent corresponding authors an email if we thought it possible that a study could be included with additional information or data, i.e. if not all index test results were reported or if the report contained an ostensible error. This resulted in sending 29 emails, from which we received 10 replies. </p> <p>After considering these 103 reports:</p> <p> <ul id="CD012399-list-0023"> <li> <p>33 reports were judged not to be a study containing data on the diagnostic value of BAL galactomannan in the diagnosis of IA, or were not published in a peer‐reviewed journal, or were a case‐control study, </p> </li> <li> <p>23 reports were judged not to use the EORTC/MSG criteria without significant modification as reference standard, </p> </li> <li> <p>28 reports were judged not to report all EORTC/MSG categories (proven, probable, possible, no IA), </p> </li> <li> <p>for 4 reports, we were unable to repeat the statistical calculations,</p> </li> <li> <p>2 reports did not report the index test specifically (but for example, as a composite with another test such as serum galactomannan), </p> </li> <li> <p>3 reports were judged to be a double publication,</p> </li> <li> <p>3 reports did not report on a per‐patient basis,</p> </li> <li> <p>1 report did not use the Platelia galactomannan assay as the galactomannan test.</p> </li> </ul> </p> <p>This led to the exclusion of 87 reports, as more criteria could be applicable per study, and the inclusion of 16 reports. As one report contained two methodologically different studies, in total 17 studies were included. </p> <p>No extra studies were found through additional searches or reference checking. Two studies were included after the receipt of additional data per email. </p> <p>The studies comprised 1634 patients in total. 'Probable' or 'proven' IA was diagnosed in 366 patients, of which 34 were specifically denoted as having 'proven' IA and 177 as having 'probable' IA. Of the remaining patients, 222 were specifically denoted as having 'possible' IA and 538 as having 'no' IA. There were 479 patients with a positive BAL galactomannan and 1155 with a negative BAL galactomannan. On average, 90.8 patients were included in a study (range 30‐210). </p> </section> <section id="CD012399-sec-0070"> <h3 class="title">Methodological quality of included studies</h3> <p>Of the 17 studies, 10 were judged to have a high risk of bias with respect to the domain of Patient Selection. These studies were unclear about whether they enrolled participants consecutively. </p> <p>Sixteen studies were judged to have a high risk of bias regarding the Index Test domain. In these studies the index test was either interpreted with knowledge of the reference standard, or using a cut‐off value that was not predefined, or this was not specified. </p> <p>Based on the signalling questions in the Reference Standard domain, 15 studies were considered at a large risk of bias. In these studies either the reference standard was interpreted with knowledge of the index test, or the reference standard was not strictly adhered to (e.g., the presence of a host criterion was not confirmed), or the authors were not specific on these points. </p> <p>Finally, with respect to the domain of Flow and Timing, 10 studies were considered to be associated with a high risk of containing bias. In these studies the review authors judged that there was (a high probability of) a significant exclusion of study participants from the analysis. </p> <p>These data are summarised in <a href="#CD012399-fig-0002">Figure 2</a> and <a href="#CD012399-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD012399-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies" data-id="CD012399-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies </p> </div> </div> </div> <div class="figure" id="CD012399-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study" data-id="CD012399-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study </p> </div> </div> </div> </section> <section id="CD012399-sec-0071"> <h3 class="title" id="CD012399-sec-0071">Findings</h3> <section id="CD012399-sec-0072"> <h4 class="title">Raw data</h4> <p>In seven studies both the 0.5 optical density index (ODI) and 1.0 ODI data were reported (see <a href="#CD012399-fig-0004">Figure 4</a>). For three of these, we even had the individual patient data (IPD) available, allowing us to investigate every possible cut‐off value. The IPD of two studies were kindly sent to us by email. In five studies the diagnostic performance of an ODI of 0.5 was reported, but not of an ODI of 1.0. Four studies only reported the 1.0 ODI data but not the 0.5 ODI data. One study reported only data at an ODI of 0.8. </p> <div class="figure" id="CD012399-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="ROC plot; all studies reporting more than 1 cut‐off value." data-id="CD012399-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>ROC plot; all studies reporting more than 1 cut‐off value.</p> </div> </div> </div> <p>Thus, the diagnostic performance of an ODI of 0.5 was reported in 12 studies (with 1123 patients), with sensitivity ranging between 52.2% and 100% and specificity ranging between 40.4% and 94.3%. The performance of an ODI of 1.0 could be determined in 11 studies (with 648 patients), with sensitivity ranging between 42.9% and 100% and specificity ranging between 75.6% and 100%. </p> <p>There was considerable variation in the reported sensitivity and specificity (see <a href="#CD012399-fig-0005">Figure 5</a> and <a href="#CD012399-fig-0006">Figure 6</a>). </p> <div class="figure" id="CD012399-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of tests: 1 ODI 0.5, 2 ODI 0.8, 3 ODI 0.85 and 0.87, 4 ODI 1.0, 5 ODI 1.5, 6 ODI 2.0, 7 ODI 2.5." data-id="CD012399-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of tests: 1 ODI 0.5, 2 ODI 0.8, 3 ODI 0.85 and 0.87, 4 ODI 1.0, 5 ODI 1.5, 6 ODI 2.0, 7 ODI 2.5. </p> </div> </div> </div> <div class="figure" id="CD012399-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="ROC Plot of all data in the review; all cut‐off values." data-id="CD012399-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>ROC Plot of all data in the review; all cut‐off values.</p> </div> </div> </div> <p><a href="#CD012399-fig-0005">Figure 5</a> shows the diagnostic accuracy estimates of the individual studies in tables and Forest plots. <a href="#CD012399-fig-0006">Figure 6</a> shows the summary ROC plot. In <a href="#CD012399-fig-0004">Figure 4</a>, a ROC plot is shown containing all studies that reported the diagnostic accuracy statistics of more than one cut‐off value. </p> <p>The variation in the reported specificity might partially be explained by chance variation, because of the small number of patients with the target condition in the various studies, on average 23.0% with a minimum of 6.2%, a maximum of 45.3% and a standard deviation of 12.4%. Above a cut‐off ODI of 1.5, the heterogeneity in specificity decreased significantly and specificity was invariably &gt; 90%. At an ODI of 1.5 or more the index test thus seems a reliable test to rule in the index disease (see <a href="#CD012399-fig-0005">Figure 5</a> and <a href="#CD012399-fig-0004">Figure 4</a>). </p> </section> <section id="CD012399-sec-0073"> <h4 class="title">Meta‐analysis</h4> <p>We performed a meta‐analysis of the pairs of sensitivity and specificity using a bivariate random‐effects approach, with cut‐off as a covariate, see <a href="./full#CD012399-tbl-0001">summary of findings Table</a> and <a href="#CD012399-fig-0007">Figure 7</a>. One included study did not report accuracy data at a cut‐off ODI of 0.5 or 1.0 (<a href="./references#CD012399-bbs2-0009" title="HengSC , ChenSC , MorrisseyCO , ThurskyK , ManserRL , DeSilvaHD . Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies. Diagnostic Microbiology and Infectious Disease2014;79(3):322‐7. ">Heng 2014</a>). We did not foresee this possibility and did not address this situation in our protocol. We chose to exclude this study from the analyses. </p> <div class="figure" id="CD012399-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Plain language summary test consequence figure" data-id="CD012399-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Plain language summary test consequence figure</p> </div> </div> </div> <p>At a cut‐off level of 0.5, this resulted in an estimated sensitivity and specificity of 0.88 (95% confidence interval (CI): 0.75 to 1.00) and 0.81 (95% CI 0.71 to 0.91), respectively. The sensitivity for cut‐off 1.0 was lower: 0.78 (95% CI 0.61 to 0.95), but this was not statistically significant (P = 0.36). The specificity for cut‐off 1.0 was higher than for cut‐off 0.5: 0.93 (95% CI 0.87 to 0.98), which was statistically significant. These summary estimates and confidence regions are graphically shown in <a href="#CD012399-fig-0008">Figure 8</a>. </p> <div class="figure" id="CD012399-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Summary estimates and confidence regions at cut‐off ODI 0.5 and 1.0." data-id="CD012399-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Summary estimates and confidence regions at cut‐off ODI 0.5 and 1.0.</p> </div> </div> </div> <p>We performed a sensitivity analysis by including from one study both the accuracy data at the ODI cut‐off level of 0.5 as well as the accuracy data at the ODI cut‐off level of 1.0, if both were reported, see <a href="#CD012399-tbl-0006">Table 5</a>. The sensitivity and specificity were 0.84 (95% CI 0.74 to 0.94) and 0.83 (95% CI 0.76 to 0.90), respectively, at a cut‐off ODI of 0.5. At a cut‐off ODI of 1.0 the sensitivity was 0.80 (95% CI 0.69 to 0.92), and the specificity 0.92 (95% CI 0.89 to 0.96). The P values were 0.66 for the sensitivity and 0.01 for the specificity. </p> <div class="table" id="CD012399-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Meta‐analysis of the pairs of sensitivity and specificity, sensitivity analysis</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Meta‐analysis of the pairs of sensitivity and specificity, sensitivity analysis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.5 ODI (n = 12)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1.0 ODI (n = 11)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 (95% CI 0.74 to 0.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 (95% CI 0.69 to 0.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (95% CI 0.76 to 0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (95% CI 0.89 to 0.96)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>CI:</b> confidence interval; <b>ODI:</b> optical density index </p> </div> </div> </section> <section id="CD012399-sec-0074"> <h4 class="title">Investigations of heterogeneity</h4> <section id="CD012399-sec-0075"> <h5 class="title">Incorporation bias</h5> <p>We examined the possibility of heterogeneity due to incorporation bias, see <a href="#CD012399-tbl-0007">Table 6</a>. We compared two groups of studies: one with the studies that incorporated serum and/or BAL galactomannan in their reference standard (or were unclear on this matter); versus a group with the studies that specifically excluded both galactomannan tests from their reference standard. In the latter group, the sensitivity and specificity were 0.98 (95% CI 0.95 to 1.00) and 0.72 (95% CI 0.53 to 0.90), respectively. In the former group the sensitivity was 0.74 (95% CI 0.63 to 0.86; P value for difference in sensitivity 0.01) and the specificity 0.91 (95% CI 0.86 to 0.95; P value for difference in specificity 0.02). </p> <div class="table" id="CD012399-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Quantification of the incorporation bias</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>with incorporation (n=12)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>without incorporation (n = 4)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (95% CI 0.63 to 0.86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98 (95% CI 0.95 to 1.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 (95% CI 0.86 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72 (95% CI 0.53 to 0.90)</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD012399-sec-0076"> <h5 class="title">The effect of pre‐selection based on a positive serum galactomannan test</h5> <p>Few studies reported this quality item. We were therefore unable to investigate this possible source of heterogeneity. </p> </section> <section id="CD012399-sec-0077"> <h5 class="title">The effect of the 2008 update of the reference standard</h5> <p>Four studies used the 2002 version, and 13 studies the 2008 version of the reference standard. Using this as a covariate had no effect on sensitivity or specificity. </p> </section> <section id="CD012399-sec-0078"> <h5 class="title">The effect of a protocol that defines the exact and explicit indication of the index test </h5> <p>Whether or not there was a strict and exact indication for performing the index test had no significant effect on sensitivity or specificity. </p> </section> <section id="CD012399-sec-0079"> <h5 class="title">Study design</h5> <p>We examined the possibility of heterogeneity due to study design, see <a href="#CD012399-tbl-0008">Table 7</a>. We compared the prospective with the retrospective (or on this matter unclear) studies. In the latter group the sensitivity and specificity were 0.94 (95% CI 0.86 to 1.00) and 0.78 (95% CI 0.65 to 0.91), respectively. In the former group the sensitivity was 0.74 (95% CI 0.60 to 0.88) and the specificity 0.91 (95% CI 0.86 to 0.96). The corresponding P values were 0.03 for the sensitivity and 0.03 for the specificity. </p> <div class="table" id="CD012399-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Quantification of the effect of the study design</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>prospective (n = 6)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>retrospective (n = 10)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (95% CI 0.60 to 0.88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (95% CI 0.86 to 1.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 (95% CI 0.86 to 0.96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (95% CI 0.65 to 0.91)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>CI:</b> confidence interval </p> </div> </div> </section> <section id="CD012399-sec-0080"> <h5 class="title">The effect of sponsoring of the study by the manufacturer of the commercially available galactomannan test </h5> <p>Whether or not the manufacturer of the commercially available galactomannan test sponsored a study had no significant effect on sensitivity or specificity. </p> </section> <section id="CD012399-sec-0081"> <h5 class="title">Other planned investigations</h5> <section id="CD012399-sec-0082"> <h6 class="title">Department(s) where the participants were recruited</h6> <p>As 10 studies were performed in haematology departments, one in a paediatric department, one in a lung transplant centre, one in various transplant departments, and in four studies the departments were not clearly specified, we were able to examine the effect of dividing the departments in two groups: haematology departments versus other or unclear departments. This division had no significant effect in our meta‐analysis, when used as a covariate. </p> </section> <section id="CD012399-sec-0083"> <h6 class="title">Additional investigations that proved not possible</h6> <p>As there was only one study that mainly included <b>children</b> a meta‐analysis on this item was not possible. As 10 studies included patients with a mix of <b>host criteria</b> , and the other studies were varied with respect to the study population, an analysis of the effect of host criteria (e.g. neutropenic patients versus the rest) was not possible. As there were no studies included in which prophylaxis was specifically withheld, an investigation into the effect of <b>anti‐mould prophylaxis</b> was not possible. </p> </section> </section> </section> <section id="CD012399-sec-0084"> <h4 class="title">Sensitivity analysis</h4> <section id="CD012399-sec-0085"> <h5 class="title">Methodological quality</h5> <p>We performed a sensitivity analysis per QUADAS‐2 domain to determine the influence of methodological quality, leaving out the studies with a high risk of bias. </p> <p>In the Index Test domain there was only one study with a low risk of bias, and in the Reference Test domain only two. A sensitivity analysis was therefore not possible for these domains. In the Patient Selection and in the Flow and Timing domains the same six studies had a low risk of bias. The sensitivity analyses were identical and can be seen in <a href="#CD012399-tbl-0009">Table 8</a>. The sensitivity and specificity in the overall group were 0.83 (95% CI 0.70 to 0.92) and 0.88 (95% CI 0.80 to 0.92), respectively. In the low risk of bias group these were lower, respectively 0.75 and 0.86. </p> <div class="table" id="CD012399-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Sensitivity analyses on methodological quality</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Sensitivity analyses on methodological quality</b> </p> <p><b>Patients and flow and timing domains</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>overall (all studies, n = 16)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>low risk of bias (n = 6)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (95% CI 0.70 to 0.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 (95% CI 0.51 to 0.89)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 (95% CI 0.80 to 0.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (95% CI 0.78 to 0.91)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>CI:</b> confidence interval </p> </div> </div> </section> <section id="CD012399-sec-0086"> <h5 class="title">Effect of reference standard definition</h5> <p>Finally, we performed a sensitivity analysis on the definition of the reference standard by determining the sensitivity and specificity when following a number of pre‐specified different definitions, see <a href="#CD012399-tbl-0010">Table 9</a>. Unfortunately, we were unable to perform a bivariate analysis comparing 'proven' versus 'probable' / 'possible' / 'no' aspergillosis, as the variance was unstable and the model did not converge. We therefore performed two univariate analyses for this definition. </p> <div class="table" id="CD012399-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Effect of reference standard definition</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Definition</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Studies</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Sensitivity</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>95% CI</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Specificity</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lower limit</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Upper limit</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lower limit</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Upper limit</b> </p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prov and Prob <b>vs</b> Pos and No </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.70</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prov <b>vs</b> Prob and Pos and No </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.73</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prov and Prob and Pos <b>vs</b> No </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.59</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>4</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Possibles excluded</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>CI:</b> confidence interval; <b>Prob:</b> probable; <b>Prov:</b> proven </p> </div> </div> <p>Excluding the participants with 'possible' aspergillosis had only a small effect on sensitivity and increased specificity slightly. Defining participants with 'probable' aspergillosis as not having the target condition decreased sensitivity and specificity. Considering participants with 'probable' and 'possible' aspergillosis as having the target condition lowered sensitivity significantly and increased specificity. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012399-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012399-sec-0087"></div> <section id="CD012399-sec-0088"> <h3 class="title" id="CD012399-sec-0088">Summary of main results</h3> <p>We included 17 studies on 1634 participants in our review. Meta‐analysis of their results led to an estimated sensitivity of 0.88 (95% CI 0.75 to 1.00) and an estimated specificity of 0.81 (95% CI 0.71 to 0.91) at a cut‐off value of an ODI of 0.5. At a cut‐off value of an ODI of 1.0 these statistics were 0.78 (95% CI 0.61 to 0.95) and 0.93 (95% CI 0.87 to 0.98), respectively.<br/> <br/> When the Platelia galactomannan test was introduced, there was no validated threshold value for use on bronchoalveolar lavage (BAL). This is reflected by the variable primary cut‐off levels used in the studies of our review. The effect of the cut‐off value on performance statistics, the threshold effect, can be seen in <a href="./full#CD012399-tbl-0001">summary of findings Table</a>. Because of the magnitude of this effect and the fact that clinical practice requires a cut‐off value, we chose not to calculate overall performance statistics but to calculate them per threshold value. </p> <p>The difference in diagnostic performance of a cut‐off value of 0.5 versus 1.0 can be illustrated using a hypothetical group of 1000 potential invasive aspergillosis (IA) patients. As an example, we will assume a disease incidence of 12%. In such a population, 120 patients will have 'proven' or 'probable' IA, and 880 will not. If we use the test at a cut‐off value of 0.5, then based on the BAL galactomannan result we will miss 14 patient with IA (sensitivity 88%, 12% false‐negative rate). And there will be 167 patients incorrectly diagnosed with invasive aspergillosis (specificity of 81%, 19% false‐positive rate). If we use the test at a cut‐off value of 1.0, we will miss 26 patients with IA (sensitivity 78%, 22% false‐negative rate). There will be 62 patients incorrectly diagnosed with invasive aspergillosis (specificity of 93%, 7% false‐positive rate). Therefore, the optimal cut‐off value will depend on the local incidence of invasive aspergillosis, in an ideal situation specifically determined for the population at hand. And, it will depend on the relative importance of false‐positive and false‐negative results, as determined by the role of the index test within the clinical pathway.<br/> <br/> Many quality features were poorly reported in the included studies, e.g. whether the clinicians were blinded, how uninterpretable or intermediate index and reference test results were dealt with, whether the results of the reference standard were known when the index test result was interpreted (and vice versa), the time interval between the execution of the index test and reference standard, and how the reference standard was exactly executed. Many studies did not confirm that all patients qualified as having a EORTC/MSG host criterion, or this seemed not to be the case in all participants. Many studies included patients with varying underlying pathologies and did not report extensively on subgroups. Studies often did not have a detailed clinical protocol specifying the indication and exact timing of the index test.<br/> <br/> The sensitivity was more heterogeneous than specificity. Part of this heterogeneity can be explained by the inclusion of small studies and the on average low prevalence of IA. The cut‐off value had a significant effect on specificity but not on sensitivity. This could also be due to the low incidence of IA. </p> <section id="CD012399-sec-0089"> <h4 class="title">Comparison with other systematic reviews</h4> <p>A number of systematic reviews on BAL galactomannan have been published in recent years, see <a href="#CD012399-tbl-0011">Table 10</a> (<a href="./references#CD012399-bbs2-0118" title="GuoYL , ChenYQ , WangK , QinSM , WuC , KongJL . Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest2010;138(4):817‐24. ">Guo 2010</a>; <a href="./references#CD012399-bbs2-0163" title="ZouM , TangL , ZhaoS , ZhaoZ , ChenL , ChenP , et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLOS One2012;7(8):e43347. [PUBMED: 22905261] ">Zou 2012</a>; <a href="./references#CD012399-bbs2-0121" title="HengSC , MorrisseyO , ChenSC , ThurskyK , ManserRL , NationRL , et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta‐analysis. Critical Reviews in Microbiology2015;41(1):124‐34. [PUBMED: 23799871] ">Heng 2015</a>). </p> <div class="table" id="CD012399-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Other systematic reviews</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Systematic review</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of<br/> studies</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies also<br/> included in our review</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cut‐off ODI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Specificity (95% CI)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD012399-bbs2-0121" title="HengSC , MorrisseyO , ChenSC , ThurskyK , ManserRL , NationRL , et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta‐analysis. Critical Reviews in Microbiology2015;41(1):124‐34. [PUBMED: 23799871] ">Heng 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>16</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>6</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.82 (0.70–0.91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (0.85–0.96)</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 (0.55–0.88)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 (0.87–0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD012399-bbs2-0118" title="GuoYL , ChenYQ , WangK , QinSM , WuC , KongJL . Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest2010;138(4):817‐24. ">Guo 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>13</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>7</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>overall</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90 (0.79‐0.96)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.90‐0.96)</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (0.70‐0.94)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.85‐0.92)</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 (0.72‐0.93)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.89‐0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD012399-bbs2-0163" title="ZouM , TangL , ZhaoS , ZhaoZ , ChenL , ChenP , et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLOS One2012;7(8):e43347. [PUBMED: 22905261] ">Zou 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>30</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>8</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.87 (0.79‐0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.85‐0.92)</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (0.76‐0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 (0.91‐0.97)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><b>CI:</b> confidence interval; <b>ODI:</b> optical density index </p> </div> </div> <p><a href="./references#CD012399-bbs2-0118" title="GuoYL , ChenYQ , WangK , QinSM , WuC , KongJL . Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest2010;138(4):817‐24. ">Guo 2010</a> wrote the first review, aiming to produce an overall sensitivity and specificity. If more than one cut‐off value was reported in a study, the cut‐off value that offered the best test performance was used. This resulted in an overall sensitivity and specificity of 0.90 and 0.94. The authors included 12 studies (not counting Becker and colleagues twice), and did not focus on a specific population.<br/> <br/> <a href="./references#CD012399-bbs2-0121" title="HengSC , MorrisseyO , ChenSC , ThurskyK , ManserRL , NationRL , et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta‐analysis. Critical Reviews in Microbiology2015;41(1):124‐34. [PUBMED: 23799871] ">Heng 2015</a> focused specifically on haematological patients and included 16 studies. At a cut‐off level of 0.5, the sensitivity was found to be 0.82 and the specificity 0.92. At a cut‐off of 1.0 sensitivity dropped to 0.75 and specificity rose to 0.95.<br/> <br/> <a href="./references#CD012399-bbs2-0163" title="ZouM , TangL , ZhaoS , ZhaoZ , ChenL , ChenP , et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLOS One2012;7(8):e43347. [PUBMED: 22905261] ">Zou 2012</a>. performed the systematic review with the largest number of studies, 30 in total (not counting Becker and colleagues twice), and included non‐English studies. The review did not focus on a specific population. A striking phenomenon in this review was the fact that increasing the cut‐off level from 0.5 to 1.0 increased the sensitivity from 0.78 to 0.94. This suggests large differences between the studies in the 0.5 and 1.0 group, overcompensating the threshold effect.<br/> <br/> We excluded from our review many of the studies that were included in the other reviews. We excluded, for example, case‐control studies, studies that did not report all EORTC/MSG categories, studies that used a modified reference standard, and non‐English studies. Of the 16 studies <a href="./references#CD012399-bbs2-0121" title="HengSC , MorrisseyO , ChenSC , ThurskyK , ManserRL , NationRL , et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta‐analysis. Critical Reviews in Microbiology2015;41(1):124‐34. [PUBMED: 23799871] ">Heng 2015</a> included, we excluded 10. Of the 30 <a href="./references#CD012399-bbs2-0163" title="ZouM , TangL , ZhaoS , ZhaoZ , ChenL , ChenP , et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLOS One2012;7(8):e43347. [PUBMED: 22905261] ">Zou 2012</a> included, we excluded 22. We excluded six of the 13 studies <a href="./references#CD012399-bbs2-0118" title="GuoYL , ChenYQ , WangK , QinSM , WuC , KongJL . Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest2010;138(4):817‐24. ">Guo 2010</a> selected.<br/> <br/> <a href="#CD012399-tbl-0011">Table 10</a> suggests that the overall performance statistics reported in <a href="./references#CD012399-bbs2-0118" title="GuoYL , ChenYQ , WangK , QinSM , WuC , KongJL . Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest2010;138(4):817‐24. ">Guo 2010</a> may be an overestimation, as the overall performance statistics are better than the statistics at the 0.5 and 1.0 ODI cut‐off level. At the 0.5 ODI cut‐off level our review estimated the sensitivity to be lower and the specificity to be higher than the other reviews. The other reviews had comparable performance statistics. At the 1.0 ODI cut‐off level all reviews were similar. </p> </section> <section id="CD012399-sec-0090"> <h4 class="title">Comparison with serum galactomannan and polymerase chain reactions (PCRs) on blood</h4> <p>Comparing our review with the Cochrane Review on serum galactomannan (<a href="./references#CD012399-bbs2-0136" title="LeeflangMM , Debets‐OssenkoppYJ , WangJ , VisserCE , ScholtenRJ , HooftL , et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD007394.pub2] ">Leeflang 2015</a>), our review seems to show that the diagnostic accuracy of the Platelia test on BAL is slightly better than when performed on serum. When using an ODI of 0.5 as a cut‐off value, the sensitivity of the serum test was 0.78 and the specificity was 0.85. At a cut‐off value of 1.0, the sensitivity was 0.71 and the specificity was 0.90. At a cut‐off value of 1.5, the sensitivity was 0.63 and the specificity was 0.93. A biological explanation of better performance on BAL could be the sampling in the immediate vicinity of the infection. </p> <p>It has been argued that airway invasion results in a rise of the amount of galactomannan in BAL fluid (<a href="./references#CD012399-bbs2-0123" title="HopeWW , KruhlakMJ , LymanCA , PetraitieneR , PetraitisV , FrancesconiA , et al. Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy. Journal of Infectious Diseases2007;195(3):455‐66. [PUBMED: 17205486] ">Hope 2007</a>). And that penetration of the endothelial cell layer by hyphae (angio‐invasive growth) could lead to more galactomannan in serum (<a href="./references#CD012399-bbs2-0138" title="Mennink‐KerstenMA , DonnellyJP , VerweijPE . Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet2004;4(6):349‐57. [PUBMED: 15172343] ">Mennink‐Kersten 2004</a>). Most likely, there is a degree of complementariness between BAL and serum galactomannan. The results of a number of studies supports this hypothesis (<a href="./references#CD012399-bbs2-0110" title="BergeronA , PorcherR , SulahianA , deBazelaireC , ChagnonK , RaffouxE , et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood2012;119(8):1831‐7; quiz 1956. [PUBMED: 22010103] ">Bergeron 2012a</a>; <a href="./references#CD012399-bbs2-0040" title="FortúnJ , Martín‐DávilaP , Gomez Garcia de la PedrosaE , SilvaJT , Garcia‐RodríguezJ , BenitoD . Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non‐hematological patients. Journal of Infection2016;72(6):738‐44. ">Fortún 2016</a>; <a href="./references#CD012399-bbs2-0047" title="HidalgoA , ParodyR , MartinoR , SánchezF , FranquetT , GiménezA , et al. Correlation between high‐resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis. European Journal of Radiology2009;71(1):55‐60. ">Hidalgo 2009</a>). </p> <p>The use of the galactomannan test in serum and BAL was validated in different studies. Both our review on serum galactomannan (<a href="./references#CD012399-bbs2-0136" title="LeeflangMM , Debets‐OssenkoppYJ , WangJ , VisserCE , ScholtenRJ , HooftL , et al. Galactomannan detection for invasive aspergillosis in immunocompromised patients. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD007394.pub2] ">Leeflang 2015</a>) and our current review showed a large amount of heterogeneity. Therefore, the comparison of the reviews on BAL and serum galactomannan is hazardous and it is not possible to determine whether the serum or BAL galactomannan obviates the use of the other test. As stated, the tests probably complement each other. It would be highly interesting for future research to focus on the relative value of both tests. </p> <p>The Cochrane Library also published a review on PCR tests on blood to diagnose invasive aspergillosis in immunocompromised patients (<a href="./references#CD012399-bbs2-0114" title="CrucianiM , MengoliC , LoefflerJ , DonnellyP , BarnesR , JonesBL , et al. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people. Cochrane Database of Systematic Reviews2015, Issue 10. [DOI: 10.1002/14651858.CD009551.pub2] ">Cruciani 2015</a>). The overall sensitivity and specificity of a single test (80.5% and 78.5%, respectively) are about comparable with the serum galactomannan test. For two consecutive positive test results these become 58.0% and 96.2%, respectively. An methodological challenge in research on PCRs to diagnose aspergillosis is the lack of a standardised protocol on how to perform the PCR. This has been improved on by for example the European Aspergillosis PCR Initiative (EAPCRI). </p> </section> </section> <section id="CD012399-sec-0091"> <h3 class="title" id="CD012399-sec-0091">Strengths and weaknesses of the review</h3> <section id="CD012399-sec-0092"> <h4 class="title">Strengths</h4> <p>The main strength of our review is the rigorous application of strict methodological criteria. This led to the exclusion of studies that were included in other reviews. For example, we excluded case‐control studies, which are often used because of the low incidence of IA. However, longitudinal cohort studies are preferable, as cases and controls are taken from the same population and the prevalence of the disease can be determined precisely. We also excluded studies that enrolled participants non‐consecutively or non‐randomly, studies that did not report all EORTC/MSG categories, and studies that modified the reference standard. </p> </section> <section id="CD012399-sec-0093"> <h4 class="title">Weaknesses</h4> <p>Because of the rigorous application of methodological criteria relatively few studies were included in our review. Even these studies are characterised by a high risk of bias, and a large amount of heterogeneity in sensitivity and specificity as well as in the distribution of patients with 'proven', 'probable', 'possible' and non‐IA. Therefore, we were not able to investigate many of the predetermined sources of heterogeneity. Notwithstanding these weaknesses, our results show that the central role that is usually given to the galactomannan test in clinical practice is justified. </p> <p>We excluded two non‐English studies from the assessment which studies were eligible for inclusion, as we are only fluent in English. In the planned update of this review in 2021, we will also include non‐English studies. </p> </section> </section> <section id="CD012399-sec-0094"> <h3 class="title" id="CD012399-sec-0094">Applicability of findings to the review question</h3> <p>We decided not to assess the concern about applicability for the patient domain as we expected to find studies with a large amount of heterogeneity and a wide range of patient populations at risk for IA. We excluded no subgroups, to be able to determine generally applicable performance statistics. Instead, we chose to carefully document the types of participants and tried to analyse heterogeneity. Such analyses require large sample sizes, which may be difficult to obtain in studies on rare infections such as invasive aspergillosis. This emphasises the need for systematic reviews. </p> <p>We expected the heterogeneity in the studies to derive from five categories:</p> <p> <ul id="CD012399-list-0024"> <li> <p>the heterogenic manifestations of the disease,</p> </li> <li> <p>the heterogenic characteristics of the patients,</p> </li> <li> <p>heterogenic study protocols,</p> </li> <li> <p>the imperfect nature of the reference standard; and</p> </li> <li> <p>incorporation bias.</p> </li> </ul> </p> <section id="CD012399-sec-0095"> <h4 class="title">Heterogeneity in disease manifestations</h4> <p>As stated in the introduction, invasive aspergillosis (IA) consists of many subforms, of which invasive pulmonary aspergillosis (IPA) is the most common variant. IPA can manifest itself as an alveolar infection or a tracheobronchitis, the latter being seen more frequently in HIV/AIDS and patients with a lung transplant. The alveolar infections can be located centrally or more peripherally. This raises the question whether the BAL procedure is of influence on the diagnostic accuracy (see "Heterogeneity in study protocols" below). And whether the sensitivity of BAL might be lower in peripherally localised aspergillosis. </p> <section id="CD012399-sec-0096"> <h5 class="title">The <i>Aspergillus</i> species involved </h5> <p>The assay performance might vary with the <i>Aspergillus</i> species involved, as some might produce different quantities of galactomannan (<a href="./references#CD012399-bbs2-0153" title="SwaninkCM , MeisJF , RijsAJ , DonnellyJP , VerweijPE . Specificity of a sandwich enzyme‐linked immunosorbent assay for detecting Aspergillus galactomannan. Journal of Clinical Microbiology1997;35(1):257‐60. [PUBMED: 8968919] ">Swanink 1997</a>; <a href="./references#CD012399-bbs2-0154" title="Taghizadeh‐ArmakiM , HedayatiMT , MoqarabzadehV , AnsariS , Mahdavi OmranS , ZarrinfarH , et al. Effect of involved aspergillus species on galactomannan in bronchoalveolar lavage of patients with invasive aspergillosis. Journal of Medical Microbiology2017;66(7):898‐904. [PUBMED: 28693685] ">Taghizadeh‐Armaki 2017</a>). A lower sensitivity has been reported in <i>A. fumigatus</i> infection in comparison with other <i>Aspergillus</i> species (13% versus 49%; P = 0.001; <a href="./references#CD012399-bbs2-0119" title="HachemRY , KontoyiannisDP , ChemalyRF , JiangY , ReitzelR , RaadI . Utility of galactomannan enzyme immunoassay and (1,3) beta‐D‐glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. Journal of Clinical Microbiology2009;47(1):129‐33. [PUBMED: 19005145] ">Hachem 2009</a>). </p> </section> </section> <section id="CD012399-sec-0097"> <h4 class="title">Heterogeneity in patient characteristics</h4> <p>The populations and the results of the studies in our review were very heterogeneous. Therefore, the interpretation and extrapolation of these results has to be performed with caution. </p> <section id="CD012399-sec-0098"> <h5 class="title">Preventative antifungal therapy</h5> <p>Preventative antifungal therapy might reduce fungal burden, leading to false‐negative results (<a href="./references#CD012399-bbs2-0037" title="EiglS , PrattesJ , ReinwaldM , ThorntonCR , ReischiesF , SpiessB , et al. Influence of mould‐active antifungal treatment on the performance of the Aspergillus‐specific bronchoalveolar lavage fluid lateral‐flow device test. International Journal of Antimicrobial Agents2015;46(4):401‐5. ">Eigl 2015</a>; <a href="./references#CD012399-bbs2-0015" title="PrattesJ , FlickH , PrüllerF , KoidlC , RaggamRB , PalfnerM , et al. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. American Journal of Respiratory and Critical Care Medicine2014;190(8):922‐9. ">Prattes 2014</a>; <a href="./references#CD012399-bbs2-0016" title="PrattesJ , LacknerM , EiglS , ReischiesF , RaggamRB , KoidlC , et al. Diagnostic accuracy of the Aspergillus‐specific bronchoalveolar lavage lateral‐flow assay in haematological malignancy patients. Mycoses2015;58(8):461‐9. ">Prattes 2015</a>; <a href="./references#CD012399-bbs2-0084" title="ReinwaldM , SpiessB , HeinzWJ , VehreschildJJ , Lass‐FlörlC , KiehlM , et al. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples. European Journal of Haematology2012;89(2):120‐7. ">Reinwald 2012a</a>). Some clinical studies reported this (<a href="./references#CD012399-bbs2-0064" title="LuongML , FilionC , LabbéAC , RoyJ , PépinJ , Cadrin‐TourignyJ , et al. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagnostic Microbiology and Infectious Disease2010;68(2):132‐9. ">Luong 2010</a>; <a href="./references#CD012399-bbs2-0011" title="MaertensJ , MaertensV , TheunissenK , MeerssemanW , MeerssemanP , MeersS , et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clinical Infectious Diseases2009;49(11):1688‐93. ">Maertens 2009</a>; <a href="./references#CD012399-bbs2-0137" title="MarrKA , BalajeeSA , McLaughlinL , TabouretM , BentsenC , WalshTJ . Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. Journal of Infectious Diseases2004;190(3):641‐9. [PUBMED: 15243943] ">Marr 2004</a>; <a href="./references#CD012399-bbs2-0077" title="ParkSY , LeeSO , ChoiSH , SungH , KimMN , ChoiCM , et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. Journal of Infection2010;61(6):492‐8. ">Park 2010</a>), while others reported the opposite (<a href="./references#CD012399-bbs2-0072" title="MusherB , FredricksD , LeisenringW , BalajeeSA , SmithC , MarrKA . Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. Journal of Clinical Microbiology2004;42(12):5517‐22. ">Musher 2004</a>), or found no effect (<a href="./references#CD012399-bbs2-0008" title="FréalleE , DecrucqK , BotterelF , BouchindhommeB , CamusD , Dei‐CasE , et al. Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real‐time PCR performance. European Journal of Clinical Microbiology and Infectious Diseases2009;28(3):223‐32. ">Frealle 2009</a>; <a href="./references#CD012399-bbs2-0012" title="NguyenMH , LeatherH , ClancyCJ , ClineC , JantzMA , KulkarniV , et al. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biology of Blood and Marrow Transplantation2011;17(7):1043‐50. ">Nguyen 2011</a>). </p> <p><a href="./references#CD012399-bbs2-0081" title="RacilZ , KocmanovaI , ToskovaM , BuresovaL , WeinbergerovaB , LengerovaM , et al. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases‐the role of factors affecting assay performance. International Journal of Infectious Diseases2011;15(12):e874‐81. ">Racil 2011</a> reported a higher sensitivity in patients who just started antifungal therapy, and a lower sensitivity after two to three days of therapy, indicating a need to perform BAL within days of starting antifungal therapy. However, <a href="./references#CD012399-bbs2-0008" title="FréalleE , DecrucqK , BotterelF , BouchindhommeB , CamusD , Dei‐CasE , et al. Diagnosis of invasive aspergillosis using bronchoalveolar lavage in haematology patients: influence of bronchoalveolar lavage human DNA content on real‐time PCR performance. European Journal of Clinical Microbiology and Infectious Diseases2009;28(3):223‐32. ">Frealle 2009</a> did not find this association. </p> <p>Our data did not allow quantification of the effect of mould‐active antifungal agents.</p> </section> <section id="CD012399-sec-0099"> <h5 class="title">Neutropenia</h5> <p>Neutropenia could cause an increase in fungal load, thereby decreasing the false‐negative rate. Conflicting results are reported. The sensitivity of BAL galactomannan varied from being no different (<a href="./references#CD012399-bbs2-0011" title="MaertensJ , MaertensV , TheunissenK , MeerssemanW , MeerssemanP , MeersS , et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clinical Infectious Diseases2009;49(11):1688‐93. ">Maertens 2009</a>) to significantly higher in neutropenic patients (<a href="./references#CD012399-bbs2-0081" title="RacilZ , KocmanovaI , ToskovaM , BuresovaL , WeinbergerovaB , LengerovaM , et al. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases‐the role of factors affecting assay performance. International Journal of Infectious Diseases2011;15(12):e874‐81. ">Racil 2011</a>). <a href="./references#CD012399-bbs2-0033" title="D'HaeseJ , TheunissenK , VermeulenE , SchoemansH , DeVliegerG , LammertijnL , et al. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. Journal of Clinical Microbiology2012;50(4):1258‐63. ">D'Haese 2012</a> reported that neutropenia influences the sensitivity of galactomannan in serum but not in BAL fluid. </p> <p>We were unable to test whether there was an influence of neutropenia.</p> </section> <section id="CD012399-sec-0100"> <h5 class="title">Colonisation</h5> <p><i>Aspergillus</i> species can colonise the pulmonary tract and, as they are ubiquitous in the environment, their spores are inhaled on a daily basis. Colonisation can lead to false‐positive results. This becomes even more relevant in populations with an underlying condition that predisposes to colonisation, such as cystic fibrosis, bronchiectasis or after a lung transplant. In such populations the specificity can be expected to be lower. Indeed, the one study in our review on lung transplant patients had a markedly low specificity (<a href="./references#CD012399-bbs2-0013" title="PasqualottoAC , XavierMO , SánchezLB , deOliveira CostaCD , SchioSM , CamargoSM , et al. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid. Transplantation2010;90(3):306‐11. ">Pasqualotto 2010</a>). </p> <p>Our data did not allow formal testing of this effect.</p> </section> <section id="CD012399-sec-0101"> <h5 class="title">Cross‐reactive moulds</h5> <p>Some non‐<i>Aspergillus</i> moulds such as <i>Histoplasma capsulatum</i> (<a href="./references#CD012399-bbs2-0139" title="MinZ , BaddleyJW , RodriguezJM , MoserSA , PatelM , HuangYT , et al. Cross‐reactivity of aspergillus galactomannan in an HIV‐infected patient with histoplasmosis. Medical Mycology Case Reports2012;1(1):119‐22. [PUBMED: 17596363; PUBMED: 24371756] ">Min 2012</a>; <a href="./references#CD012399-bbs2-0142" title="NarreddyS , ChandrasekarPH . False‐positive Aspergillus galactomannan (GM) assay in histoplasmosis. Journal of Infection2008; Vol. 56, issue 1:80‐1. [PUBMED: 17983658] ">Narreddy 2008</a>; <a href="./references#CD012399-bbs2-0159" title="WheatLJ , HackettE , DurkinM , ConnollyP , PetraitieneR , WalshTJ , et al. Histoplasmosis‐associated cross‐reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clinical and Vaccine Immunology2007;14(5):638‐40. [PUBMED: 17344352] ">Wheat 2007</a>), <i>Penicillium marneffei</i> (<a href="./references#CD012399-bbs2-0124" title="HuangYT , HungCC , LiaoCH , SunHY , ChangSC , ChenYC . Detection of circulating galactomannan in serum samples for diagnosis of penicillium marneffei Infection and cryptococcosis among patients infected with human immunodeficiency virus. Journal of Clinical Microbiology2007;45(9):2858‐62. [PUBMED: 17596363] ">Huang 2007</a>; <a href="./references#CD012399-bbs2-0147" title="RimekD , ZimmermannT , HartmannM , PrariyachatigulC , KappeR . Disseminated penicillium marneffei infection in an HIV‐positive female from Thailand in Germany. Mycoses1999;42 Suppl 2:25‐8. [PUBMED: 10865899] ">Rimek 1999</a>), <i>Fusarium oxysporum</i> (<a href="./references#CD012399-bbs2-0143" title="NucciM , CarlesseF , CappellanoP , VaronAG , SeberA , GarnicaM , et al. Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing. PLOS One2014;9(1):e87784. [PUBMED: 24489964] ">Nucci 2014</a>; <a href="./references#CD012399-bbs2-0155" title="TortoranoAM , EspostoMC , PrigitanoA , GranciniA , OssiC , CavannaC , et al. Cross‐reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme‐linked immunosorbent assay. Journal of Clinical Microbiology2012;50(3):1051‐3. [PUBMED: 22205818] ">Tortorano 2012</a>) and <i>Alternaria</i> species (<a href="./references#CD012399-bbs2-0129" title="KappeR , Schulze‐BergeA . New cause for false‐positive results with the Pastorex Aspergillus antigen latex agglutination test. Journal of Clinical Microbiology1993;31(9):2489‐90. [PUBMED: 8408572] ">Kappe 1993</a>) may cross‐react with galactomannan epitopes. These potential cross‐reactions could be important in the geographic areas in which these moulds are endemic. We were unable to test this hypothesis. </p> </section> <section id="CD012399-sec-0102"> <h5 class="title">Cross‐reactive epitopes</h5> <p>Betalactam antibiotics such as amoxicillin‐clavulanate and piperacillin‐tazobactam, which are often given to these patients, have been reported to caused false‐positive results, as they are derived from natural compounds produced by the genus <i>Penicillium</i> (<a href="./references#CD012399-bbs2-0109" title="Bart‐DelabesseE , BasileM , Al JijakliA , SouvilleD , GayF , PhilippeB , et al. Detection of aspergillus galactomannan antigenemia to determine biological and clinical implications of beta‐lactam treatments. Journal of Clinical Microbiology2005;43(10):5214‐20. [PUBMED: 16207986] ">Bart‐Delabesse 2005</a>; <a href="./references#CD012399-bbs2-0111" title="BoonsarngsukV , NiyompattamaA , TeosirimongkolC , SriwanichrakK . False‐positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics. Scandinavian Journal of Infectious Diseases2010;42(6‐7):461‐8. [PUBMED: 20192889] ">Boonsarngsuk 2010</a>). </p> <p>We had insufficient data to examine this possible relation.</p> </section> </section> <section id="CD012399-sec-0103"> <h4 class="title">Heterogeneity in study protocols</h4> <p>The study protocol has a major impact on test performance. For example, it can define a certain period of fever unresponsive to broad spectrum antibiotics as an indication for the index test. A shorter period of fever corresponds with an earlier disease phase that will be harder to detect. Shortening the period will therefore lower the estimated sensitivity of the index test. A second example is that the study protocol defines the study population and that disease prevalence influences diagnostic test accuracy. For instance, a population with a high disease prevalence may also include more severe cases of disease (<a href="./references#CD012399-bbs2-0141" title="MulherinSA , MillerWC . Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Annals of Internal Medicine2002;137(7):598‐602. [PUBMED: 12353947] ">Mulherin 2002</a>). </p> <section id="CD012399-sec-0104"> <h5 class="title">Interpretation of the reference standard</h5> <p>The composite nature of the reference standard – that states that "[e]very reasonable attempt should be made to exclude an alternative etiology" for lower respiratory signs – raises the question how far one should go to exclude other aetiologies, and whether this diagnostic work‐up should be standardised in a study. For example, a patient with a pulmonary nodule and a negative BAL culture will be classified as having 'possible' aspergillosis. However, if a trans‐thoracic biopsy was performed, the patient would have been classified as having 'proven' aspergillosis if it was positive. The indication for trans‐thoracic biopsy as well as the extent of the microbiological work‐up on BAL in case of suspected IA differs among clinics. This introduces bias. Moreover, as the reference standard calls for an evaluation of the possibility of alternative aetiologies, subjectivity is introduced. </p> </section> <section id="CD012399-sec-0105"> <h5 class="title">Multiple samples per patient</h5> <p>The number of measurements per patient can also introduce bias. Sensitivity and specificity are either calculated on a per‐patient basis or a per‐test basis. This means a patient is labelled as a case patient or as a control patient depending on whether they developed IA during their treatment course (per‐patient basis) or had it at the time of the index test (per‐test). In case of per‐patient analysis, a larger number of samples will result in a higher likelihood of a positive test due to chance (and usually, the better the performance statistics will be). Both per‐patient and per‐test analysis can lead to bias when different numbers of samples are obtained for each patient, or if the timing of samples is not systematically applied to each patient. The more they are clustered around the moment of infection, the better the performance statistics will become. To avoid these problems, some included studies used only one index test per patient. For example, the first one performed (<a href="./references#CD012399-bbs2-0001" title="BeckerMJ , LugtenburgEJ , CornelissenJJ , Van DerScheeC , HoogstedenHC , DeMarieS . Galactomannan detection in computerized tomography‐based broncho‐alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. British Journal of Haematology2003;121(3):448‐57. ">Becker 2003 ‐‐ part I</a>), or the one with the highest result (<a href="./references#CD012399-bbs2-0006" title="deMolM , deJongsteJC , vanWestreenenM , MerkusPJF , deVriesAH , Hop WimCJ , et al. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan. Pediatric Pulmonology2013;48(8):789‐96. ">de Mol 2013</a>) Effectively, the latter strategy still uses multiple tests per patient. </p> </section> <section id="CD012399-sec-0106"> <h5 class="title">Bronchoalveolar lavage (BAL) procedure</h5> <p>Computerised tomography (CT) scans are ubiquitously available, and should preferably be used to guide the lavage. In that setting the probability of a misguided lavage, for example due to multifocal and multifactorial pathology, seems low. However, it is not known which fraction of the BAL is associated with the most accurate test result. Often the homogenised alveolar sample is used. <a href="./references#CD012399-bbs2-0049" title="HsuLY , DingY , PhuaJ , KohLP , ChanDS , KhooKL , et al. Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients. BMC Infectious Diseases2010;10:44. ">Hsu 2010</a> tested the bronchial sample. Comparative studies found that sensitivity may be lower when testing bronchial samples (<a href="./references#CD012399-bbs2-0081" title="RacilZ , KocmanovaI , ToskovaM , BuresovaL , WeinbergerovaB , LengerovaM , et al. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases‐the role of factors affecting assay performance. International Journal of Infectious Diseases2011;15(12):e874‐81. ">Racil 2011</a>, <a href="./references#CD012399-bbs2-0163" title="ZouM , TangL , ZhaoS , ZhaoZ , ChenL , ChenP , et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLOS One2012;7(8):e43347. [PUBMED: 22905261] ">Zou 2012</a>). It could also depend on the localisation of the infection. The volume of aspirated fluid is another parameter that seems important as higher volumes have been associated with higher false‐negative rates (<a href="./references#CD012399-bbs2-0081" title="RacilZ , KocmanovaI , ToskovaM , BuresovaL , WeinbergerovaB , LengerovaM , et al. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases‐the role of factors affecting assay performance. International Journal of Infectious Diseases2011;15(12):e874‐81. ">Racil 2011</a>). Correction of the test result using a dilution marker might be a solution, as a universal standard seems unfeasible (<a href="./references#CD012399-bbs2-0146" title="RennardSI , BassetG , LecossierD , O'DonnellKM , PinkstonP , MartinPG , et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. Journal of Applied Physiology1986;60(2):532‐8. [PUBMED: 3512509] ">Rennard 1986</a>). False‐positive results could additionally result from contamination at processing, transport, or testing. This has been reported for Plasmalyte, which is used as lavage fluid and components of which are produced by <i>A.niger</i> (<a href="./references#CD012399-bbs2-0120" title="HageCA , ReynoldsJM , DurkinM , WheatLJ , KnoxKS . Plasmalyte as a cause of false‐positive results for Aspergillus galactomannan in bronchoalveolar lavage fluid. Journal of Clinical Microbiology2007; Vol. 45, issue 2:676‐7. [PUBMED: 17166959] ">Hage 2007</a>, <a href="./references#CD012399-bbs2-0150" title="SprietI , LagrouK , MaertensJ , WillemsL , WilmerA , WautersJ . Plasmalyte: no longer a culprit in causing false‐positive galactomannan test results. Journal of Clinical Microbiology2016;54(3):795‐7. [PUBMED: 26719444] ">Spriet 2016</a>). Protracted storage has also been reported to lead to false‐negative results (<a href="./references#CD012399-bbs2-0117" title="DufresneSF , BeaucheminS , LavalleeC , LaverdiereM . Instability of Aspergillus galactomannan in stored clinical samples. Journal of Clinical Microbiology2014; Vol. 52, issue 12:4435‐6. [PUBMED: 25253794] ">Dufresne 2014</a>, <a href="./references#CD012399-bbs2-0125" title="JohnsonGL , SarkerSJ , HillK , TsitsikasDA , MorinA , BustinSA , et al. Significant decline in galactomannan signal during storage of clinical serum samples. International Journal of Molecular Sciences2013;14(7):12970‐7. [PUBMED: 23797658] ">Johnson 2013</a>, <a href="./references#CD012399-bbs2-0126" title="JohnsonGL , SarkerSJ , BustinSA , AgrawalSG . Insufficient demonstration of long‐term stability of aspergillus galactomannan. Journal of Clinical Microbiology2014;52(11):4118. [PUBMED: 25324240] ">Johnson 2014</a>; <a href="./references#CD012399-bbs2-0131" title="KimptonG , WhitePL , BarnesRA . The effect of sample storage on the performance and reproducibility of the galactomannan EIA test. Medical Mycology2014;52(6):618‐26. [PUBMED: 24850886] ">Kimpton 2014</a>; <a href="./references#CD012399-bbs2-0160" title="WheatLJ , NguyenMH , AlexanderBD , DenningD , CaliendoAM , LyonGM , et al. Reply to “Insufficient Demonstration of Long‐Term Stability of Aspergillus Galactomannan”. Journal of Clinical Microbiology2014;52(11):4119. [PUBMED: 25324241] ">Wheat 2014</a>). </p> <p>As the included studies did not use or did not report a study protocol, or had incomparable protocols, we were unable to quantify this bias. We did exclude studies with a varying number of tests per patient that reported performance statistics on a per‐test basis. </p> </section> <section id="CD012399-sec-0107"> <h5 class="title">Study design</h5> <p>A prospective study is preferable to a retrospective study. It results in a cohort that is better defined in terms of patient characteristics. Moreover, the index test and reference standard are often performed in a more standardised fashion. This is of special importance when the timing of the index test is of influence. In our meta‐analysis, the study design had a large effect on the sensitivity and specificity, perhaps corresponding with an earlier BAL in the prospective studies. </p> </section> </section> <section id="CD012399-sec-0108"> <h4 class="title">The reference standard</h4> <p>Although the first three sources of heterogeneity could be solved by meta‐analysis of large studies that are methodologically well construed, two challenges remain that are currently unsolvable. </p> <section id="CD012399-sec-0109"> <h5 class="title">Misclassification bias</h5> <p>There is no reliable reference standard for IA. <i>Aspergillus</i> infection can be proven by the isolation and culture of the organism from a normally sterile site (<a href="./references#CD012399-bbs2-0116" title="DePauwB , WalshTJ , DonnellyJP , StevensDA , EdwardsJE , CalandraT , et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clinical Infectious Diseases2008;46(12):1813‐21. ">De Pauw 2008</a>). However, biopsies are associated with complications, and examination of tissue samples and BAL can be negative despite ultimately proven infection. This difficulty is reflected by the reference standard that contains grades of certainty, and the fact that it had to be revised. The reference standard contains many subjective items. It calls for the interpretation of tests by radiologists, pathologists, microbiologists and pulmonologists. This can be associated with intra‐ and inter‐observer variability. Misclassification will result in a wrong estimation of the prevalence and can underestimate a tests' sensitivity and specificity.<br/> <br/> A non‐blinded study can lead to further underestimation as a clinician who is aware of a positive test result could start therapy. This could in turn prevent the reference standard from ever becoming positive. Because of the imperfect nature of the reference standard and the promising first study results, the index test has already become part of the current reference standard. It can be argued that blinding a clinician from the results is unethical. In 2013, a randomised controlled trial confirmed the clinical value of galactomannan testing on serum samples (<a href="./references#CD012399-bbs2-0140" title="MorrisseyCO , ChenSC , SorrellTC , MillikenS , BardyPG , BradstockKF , et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high‐risk haematology patients: a randomised controlled trial. Lancet2013;13(6):519‐28. [PUBMED: 23639612] ">Morrissey 2013</a>). </p> <p>A relatively minor problem with the reference standard is the fact that it focuses on invasive fungal disease, not aspergillosis. If microscopy or cytology is positive as a mycological criterion but all cultures are negative, it is not clear whether a patient has aspergillosis or not. If the patient also has a host and clinical criterion, he has 'probable' invasive <b>mycosis</b> . But whether he has 'probable' invasive <b>aspergillosis</b> is unclear. </p> </section> <section id="CD012399-sec-0110"> <h5 class="title">Moment of infection</h5> <p>Not only is there no reliable way to determine whether a patient has the target disease, but due to the insidious and protracted course of the disease it is also not possible to determine the moment a patient became infected. This makes it hard to interpret a positive index test that was performed a number of days before the reference test was performed. This is called disease progression bias. Was it an early sign of the disease, a false‐positive test or a different episode of the same disease that was cured or spontaneously resolved? </p> <p>The composite nature of the reference standard makes it nearly unavoidable that there will be varying time intervals between the index and reference test. Moreover, as the reference test consists of multiple tests, it is not a single point in time. </p> <p>Although misclassification and disease progression bias could have played a role in the large amount of heterogeneity in our review, it is not possible to quantify the effect of these biases. </p> </section> </section> <section id="CD012399-sec-0111"> <h4 class="title">Incorporation bias</h4> <p>A second and related major difficulty is incorporation bias. As stated, the index test is part of the current reference standard. Following this definition in a diagnostic study leads to a form of circular reasoning, overestimating sensitivity and specificity. As an extreme example, if the index test is only performed in case of a CT scan showing a clinical criterion, a positive index test will result in a positive reference standard and the specificity will always be 100%. On the other hand, not incorporating the galactomannan test will underestimate specificity (and to a lesser extent sensitivity) as a negative reference standard does not exclude the disease.<br/> <br/> In our review, we found a large difference between studies that did and did not avoid incorporation bias. Strangely enough, the sensitivity increased spectacularly in the group that avoided incorporation bias. This could be due to chance, because of the relatively low number of studies in this group (n = 4); or due to the fact that the studies were performed in populations in which false‐negative results are rare. The studies were three prospective studies, including only neutropenic haematological patients, and the only study on lung transplant patients. </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012399-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD012399-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies" data-id="CD012399-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns graph: review authors' judgements about each domain presented as percentages across included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study" data-id="CD012399-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias and applicability concerns summary: review authors' judgements about each domain for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="ROC plot; all studies reporting more than 1 cut‐off value." data-id="CD012399-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>ROC plot; all studies reporting more than 1 cut‐off value.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of tests: 1 ODI 0.5, 2 ODI 0.8, 3 ODI 0.85 and 0.87, 4 ODI 1.0, 5 ODI 1.5, 6 ODI 2.0, 7 ODI 2.5." data-id="CD012399-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of tests: 1 ODI 0.5, 2 ODI 0.8, 3 ODI 0.85 and 0.87, 4 ODI 1.0, 5 ODI 1.5, 6 ODI 2.0, 7 ODI 2.5. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="ROC Plot of all data in the review; all cut‐off values." data-id="CD012399-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>ROC Plot of all data in the review; all cut‐off values.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Plain language summary test consequence figure" data-id="CD012399-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Plain language summary test consequence figure</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Summary estimates and confidence regions at cut‐off ODI 0.5 and 1.0." data-id="CD012399-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Summary estimates and confidence regions at cut‐off ODI 0.5 and 1.0.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-TST-001" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-TST-001.xxx" target="_blank"><b></b></a></p> </div><img alt="ODI 0.5." data-id="CD012399-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-001.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 1</div> <div class="figure-caption"> <p>ODI 0.5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#CD012399-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-001.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-TST-002" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-TST-002.xxx" target="_blank"><b></b></a></p> </div><img alt="ODI 0.8." data-id="CD012399-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-002.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 2</div> <div class="figure-caption"> <p>ODI 0.8.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#CD012399-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-002.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-TST-003" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-TST-003.xxx" target="_blank"><b></b></a></p> </div><img alt="ODI 0.85 and 0.87." data-id="CD012399-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-003.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 3</div> <div class="figure-caption"> <p>ODI 0.85 and 0.87.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#CD012399-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-003.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-TST-004" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-TST-004.xxx" target="_blank"><b></b></a></p> </div><img alt="ODI 1.0." data-id="CD012399-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-004.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 4</div> <div class="figure-caption"> <p>ODI 1.0.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#CD012399-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-004.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-TST-005" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-TST-005.xxx" target="_blank"><b></b></a></p> </div><img alt="ODI 1.5." data-id="CD012399-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-005.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 5</div> <div class="figure-caption"> <p>ODI 1.5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#CD012399-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-005.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-TST-006" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-TST-006.xxx" target="_blank"><b></b></a></p> </div><img alt="ODI 2.0." data-id="CD012399-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-006.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 6</div> <div class="figure-caption"> <p>ODI 2.0.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#CD012399-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-006.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012399-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/urn:x-wiley:14651858:media:CD012399:CD012399-TST-007" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_t/tCD012399-TST-007.xxx" target="_blank"><b></b></a></p> </div><img alt="ODI 2.5." data-id="CD012399-fig-0015" src="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-007.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Test 7</div> <div class="figure-caption"> <p>ODI 2.5.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#CD012399-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/media/CDSR/CD012399/image_n/nCD012399-TST-007.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012399-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Summary of findings table</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>What is the diagnostic accuracy of the Platelia© <i>Aspergillus</i> ELISA for invasive aspergillosis in immunocompromised patients? </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patients/population</b>: immunocompromised patients, mostly neutropenic haematology patients. </p> <p><b>Prior testing</b>: varied. </p> <p><b>Index test</b>: the Platelia© ELISA, a sandwich ELISA for galactomannan, an <i>Aspergillus</i> antigen. </p> <p><b>Importance</b>: currently regarded as the most accurate test to diagnose invasive aspergillosis. </p> <p><b>Reference standard</b>: the EORTC/MSG criteria. </p> <p><b>Studies</b>: cohort studies reporting all EORTC‐MSG categories and of which the 2 × 2 or 4 × 2 table contained not more than one index test per participant. </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Cut‐off value</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>No. of participants</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Summary estimates (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Implications</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="1" valign=""> <p><b>Quality and Comments</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>0.5 ODI (12 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>229 with proven or probable IA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity: 0.88 (95% CI 0.75 to 1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>At a prevalence of 12%, 120 out of 1000 patients will develop proven or probable IA. Of these, 14 will be missed. </p> <p>Of the 880 patients with possible or no IA, 167 will have a false‐positive test result and may be unnecessarily treated. Of all 273 patients with a positive test, 106 will indeed have proven or probable IA; of all 727 negative tests, 14 will have IA after all (2%). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign=""> <p>All studies except one had a high risk of bias in two or more domains.</p> <p>For all studies the concerns regarding applicability were low.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>894 with possible or no IA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Specificity: 0.81 (95% CI 0.71 to 0.91)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>1.0 ODI (11 studies)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177 with proven or probable IA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sensitivity: 0.78 (95% CI 0.61 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>At a prevalence of 12%, 120 out of 1000 patients will develop proven or probable IA. Of these, 26 will be missed. </p> <p>Of the 880 patients with possible or no IA, 62 will have a false‐positive test result and may be unnecessarily treated. Of all 156 patients with a positive test, 94 will indeed have proven or probable IA; of all 844 negative tests, 26 will have IA after all (3%). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>594 with possible or no IA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Specificity: 0.93 (95% CI 0.87 to 0.98)</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>Note, the populations and results were very heterogeneous. Therefore, interpretation and extrapolation of these results has to be performed with caution. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><b>CI:</b> confidence interval;<b>IA:</b> invasive aspergillosis; <b>ODI:</b> optical density index </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings</span> <span class="table-title">Summary of findings table</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">EORTC/MSG criteria, 2008 version</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Host criterion</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical criterion</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Microbiological criterion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Possible IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Probable IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><b>IA:</b> invasive aspergillosis </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">EORTC/MSG criteria, 2008 version</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">EORTC/MSG criteria, 2002 version</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Host criterion</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical criterion</b> </p> <p><b>(1 major or 2 minor)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Microbiological criterion</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not required</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Possible IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p>Either one of these is required</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Probable IA</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Required</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p><b>IA:</b> invasive aspergillosis </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">EORTC/MSG criteria, 2002 version</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Full EORTC/MSG criteria, 2008 version</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Possible / probable invasive aspergillosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Host factors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0005"> <li> <p>Recent history of neutropenia (&lt; 0.5 x 10 9 neutrophils/L [&lt; 500 neutrophils/mm<sup>3</sup>] for &gt; 10 days) temporally related to the onset of fungal disease. </p> </li> <li> <p>Receipt of an allogeneic stem cell transplant</p> </li> <li> <p>Prolonged use of corticosteroids (excluding among patients with allergic bronchopulmonary aspergillosis) at a mean minimum dose of 0.3 mg/kg/day of prednisone equivalent for &gt; 3 weeks </p> </li> <li> <p>Treatment with other recognized T cell immunosuppressants, such as cyclosporine, TNF‐a blockers, specific monoclonal antibodies (such as alemtuzumab), or nucleoside analogues during the past 90 days </p> </li> <li> <p>Inherited severe immunodeficiency (such as chronic granulomatous disease or severe combined immunodeficiency </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0006"> <li> <p>Lower respiratory tract fungal disease (every reasonable attempt should be made to exclude an alternative etiology), with the presence of 1 of the following 3 signs on CT </p> <ul id="CD012399-list-0007"> <li> <p>Dense, well‐circumscribed lesions(s) with or without a halo sign</p> </li> <li> <p>Air‐crescent sign</p> </li> <li> <p>Cavity</p> </li> </ul> </li> <li> <p>Tracheobronchitis: tracheobronchial ulceration, nodule, pseudomembrane, plaque, or eschar seen on bronchoscopic analysis </p> </li> <li> <p>Sinonasal infection: Imaging showing sinusitis plus at least 1 of the following 3 signs: </p> <ul id="CD012399-list-0008"> <li> <p>Acute localized pain (including pain radiating to the eye)</p> </li> <li> <p>Nasal ulcer with black eschar</p> </li> <li> <p>Extension from the paranasal sinus across bony barriers, including into the orbit</p> </li> </ul> </li> <li> <p>CNS infection: 1 of the following 2 signs:</p> <ul id="CD012399-list-0009"> <li> <p>Focal lesions on imaging</p> </li> <li> <p>Meningeal enhancement on MRI</p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mycological criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Direct test (cytology, direct microscopy, or culture) showing mold in sputum, bronchoalveolar lavage fluid, bronchial brush, or sinus aspirate samples, indicated by 1 of the following: </p> <p> <ul id="CD012399-list-0010"> <li> <p>Presence of fungal elements indicating a mold</p> </li> <li> <p>Recovery by culture of a mold (e.g., <i>Aspergillus</i> , <i>Fusarium, Zygomycetes,</i> or<i>Scedosporium</i> species) </p> </li> </ul> </p> <p>Indirect tests (detection of antigen or cell‐wall constituents)</p> <p> <ul id="CD012399-list-0011"> <li> <p>Aspergillosis: Galactomannan antigen detected in plasma, serum, bronchoalveolar lavage fluid, or CSF </p> </li> <li> <p>Invasive fungal disease other than cryptococcosis and zygomycoses: b‐d‐glucan detected in serum </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Proven aspergillosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Criteria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0012"> <li> <p>Histopathologic, cytopathologic, or direct microscopic examination of a specimen obtained by needle aspiration or biopsy in which hyphae or melanized yeast‐like forms are seen accompanied by evidence of associated tissue damage; or, </p> </li> <li> <p>Recovery of a mold or “black yeast” by culture of a specimen obtained by a sterile procedure from a normally sterile and clinically or radiologically abnormal site consistent with an infectious disease process, excluding bronchoalveolar lavage fluid, a cranial sinus cavity specimen, and urine. </p> </li> </ul> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Full EORTC/MSG criteria, 2008 version</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Full EORTC/MSG criteria, 2002 version</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Possible / Probable invasive aspergillosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Host factors</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0013"> <li> <p>Neutropenia (&lt; 500 neutrophils/mm<sup>3</sup> for &gt; 10 days) </p> </li> <li> <p>Persistent fever for &gt; 96 h refractory to appropriate broad‐spectrum antibacterial treatment in high‐risk patients </p> </li> <li> <p>Body temperature either &gt; 38°C or &lt; 36°C and any of the following predisposing conditions: prolonged neutropenia (&gt; 10 days) in previous 60 days, recent or current use of significant immunosuppressive agents in previous 30 days, proven or probable invasive fungal infection during previous episode of neutropenia, or coexistence of symptomatic AIDS </p> </li> <li> <p>Signs and symptoms indicating graft‐versus‐host disease, particularly severe (grade ≥ 2) or chronic extensive disease </p> </li> <li> <p>Prolonged (&gt; 3 weeks) use of corticosteroids in previous 60 days</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Clinical criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Must be related to site of microbiological criteria and temporally related to current episode </p> <p> <ul id="CD012399-list-0014"> <li> <p>Lower respiratory tract infection</p> <ul id="CD012399-list-0015"> <li> <p>Major: Any of the following new infiltrates on CT imaging: halo sign, air‐crescent sign, or cavity within area of consolidation, in absence of infection by organisms that may lead to similar radiological findings including cavitation, such as Mycobacterium, Legionella, and Nocardia species. </p> </li> <li> <p>Minor: Symptoms of lower respiratory tract infection (cough, chest pain, haemoptysis, dyspnoea); physical finding of pleural rub; any new infiltrate not fulfilling major criterion; pleural effusion </p> </li> </ul> </li> <li> <p>Sinonasal infection</p> <ul id="CD012399-list-0016"> <li> <p>Major: Suggestive radiological evidence of invasive infection in sinuses (i.e., erosion of sinus walls or extension of infection to neighbouring structures, extensive skull base destruction) </p> </li> <li> <p>Minor: Upper respiratory symptoms (e.g. nasal discharge, stuffiness); nose ulceration or eschar of nasal mucosa or epistaxis; periorbital swelling; maxillary tenderness; black necrotic lesions or perforation of hard palate </p> </li> </ul> </li> <li> <p>CNS infection</p> <ul id="CD012399-list-0017"> <li> <p>Major: Radiological evidence suggesting CNS infection (e.g. mastoiditis or other parameningeal foci, extradural empyema, intraparenchymal brain or spinal cord mass lesion) </p> </li> <li> <p>Minor: Focal neurological symptoms and signs (including focal seizures, hemiparesis, and cranial nerve palsies); mental changes; meningeal irritation findings; abnormalities in CSF biochemistry and cell count (provided that CSF is negative for other pathogens by culture or microscopy and negative for malignant cell </p> </li> </ul> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Microbiological criteria</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p> <ul id="CD012399-list-0018"> <li> <p>Positive result of culture for mold (including <i>Aspergillus</i> , <i>Fusarium</i> , or <i>Scedosporium</i> species or a <i>Zygomycetes</i> ) or <i>Cryptococcus neoformans</i> or an endemic fungal pathogen from sputum or bronchoalveolar lavage fluid samples </p> </li> <li> <p>Positive result of culture or findings of cytologic/direct microscopic evaluation for mold from sinus aspirate specimen </p> </li> <li> <p>Positive findings of cytologic/direct microscopic evaluation for mold or Cryptococcus species from sputum or bronchoalveolar lavage fluid samples </p> </li> <li> <p>Positive result for <i>Aspergillus</i> antigen in specimens of bronchoalveolar lavage fluid, CSF, or ≥ 2 blood samples </p> </li> <li> <p>Positive result for cryptococcal antigen in blood sample</p> </li> <li> <p>Positive findings of cytologic or direct microscopic examination for fungal elements in sterile body fluid samples (e.g. Cryptococcus species in CSF) </p> </li> <li> <p>Positive result for Histoplasma capsulatum antigen in blood, urine, or CSF specimens</p> </li> <li> <p>Two positive results of culture of urine samples for yeasts in absence of urinary catheter </p> </li> <li> <p>Candida casts in urine in absence of urinary catheter</p> </li> <li> <p>Positive result of blood culture for Candida species</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Proven aspergillosis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Criterion</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Histopathologic or cytopathologic examination showing hyphae from needle aspiration or biopsy specimen with evidence of associated tissue damage (either microscopically or unequivocally by imaging); or positive culture result for a sample obtained by sterile procedure from normally sterile and clinically or radiologically abnormal site consistent with infection, excluding urine and mucous membranes. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Full EORTC/MSG criteria, 2002 version</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Meta‐analysis of the pairs of sensitivity and specificity, sensitivity analysis</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Meta‐analysis of the pairs of sensitivity and specificity, sensitivity analysis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>0.5 ODI (n = 12)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1.0 ODI (n = 11)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.84 (95% CI 0.74 to 0.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80 (95% CI 0.69 to 0.92)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (95% CI 0.76 to 0.90)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (95% CI 0.89 to 0.96)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><b>CI:</b> confidence interval; <b>ODI:</b> optical density index </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">Meta‐analysis of the pairs of sensitivity and specificity, sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0007"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Quantification of the incorporation bias</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>with incorporation (n=12)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>without incorporation (n = 4)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (95% CI 0.63 to 0.86)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98 (95% CI 0.95 to 1.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 (95% CI 0.86 to 0.95)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72 (95% CI 0.53 to 0.90)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span> <span class="table-title">Quantification of the incorporation bias</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0008"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Quantification of the effect of the study design</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>prospective (n = 6)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>retrospective (n = 10)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (95% CI 0.60 to 0.88)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (95% CI 0.86 to 1.00)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91 (95% CI 0.86 to 0.96)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (95% CI 0.65 to 0.91)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><b>CI:</b> confidence interval </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span> <span class="table-title">Quantification of the effect of the study design</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0009"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Sensitivity analyses on methodological quality</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="3" rowspan="1" valign=""> <p><b>Sensitivity analyses on methodological quality</b> </p> <p><b>Patients and flow and timing domains</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>overall (all studies, n = 16)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>low risk of bias (n = 6)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>sensitivity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83 (95% CI 0.70 to 0.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 (95% CI 0.51 to 0.89)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>specificity</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88 (95% CI 0.80 to 0.92)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (95% CI 0.78 to 0.91)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p><b>CI:</b> confidence interval </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span> <span class="table-title">Sensitivity analyses on methodological quality</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0010"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Effect of reference standard definition</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""></td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Definition</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Studies</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Sensitivity</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>95% CI</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Specificity</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>95% CI</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lower limit</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Upper limit</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Lower limit</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Upper limit</b> </p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prov and Prob <b>vs</b> Pos and No </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.83</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.70</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prov <b>vs</b> Prob and Pos and No </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.73</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Prov and Prob and Pos <b>vs</b> No </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.59</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>4</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Possibles excluded</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><b>CI:</b> confidence interval; <b>Prob:</b> probable; <b>Prov:</b> proven </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span> <span class="table-title">Effect of reference standard definition</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012399-tbl-0011"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Other systematic reviews</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Systematic review</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of<br/> studies</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Number of studies also<br/> included in our review</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Cut‐off ODI</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Sensitivity (95% CI)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Specificity (95% CI)</b> </p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD012399-bbs2-0121" title="HengSC , MorrisseyO , ChenSC , ThurskyK , ManserRL , NationRL , et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta‐analysis. Critical Reviews in Microbiology2015;41(1):124‐34. [PUBMED: 23799871] ">Heng 2015</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>16</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>6</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.82 (0.70–0.91)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (0.85–0.96)</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.75 (0.55–0.88)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 (0.87–0.98)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p><a href="./references#CD012399-bbs2-0118" title="GuoYL , ChenYQ , WangK , QinSM , WuC , KongJL . Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest2010;138(4):817‐24. ">Guo 2010</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>13</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="3" valign=""> <p>7</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>overall</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90 (0.79‐0.96)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.90‐0.96)</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (0.70‐0.94)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.85‐0.92)</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 (0.72‐0.93)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.94 (0.89‐0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><a href="./references#CD012399-bbs2-0163" title="ZouM , TangL , ZhaoS , ZhaoZ , ChenL , ChenP , et al. Systematic review and meta‐analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLOS One2012;7(8):e43347. [PUBMED: 22905261] ">Zou 2012</a> </p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>30</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>8</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.5</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.87 (0.79‐0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.89 (0.85‐0.92)</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86 (0.76‐0.92)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 (0.91‐0.97)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><b>CI:</b> confidence interval; <b>ODI:</b> optical density index </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span> <span class="table-title">Other systematic reviews</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/full#CD012399-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012399-tbl-0012"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p>Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">1 ODI 0.5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1123</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">2 ODI 0.8 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>414</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">3 ODI 0.85 and 0.87 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>286</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">4 ODI 1.0 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>911</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">5 ODI 1.5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">6 ODI 2.0 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Test" rowspan="1" valign=""> <p class="subgroupTitle">7 ODI 2.5 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> </tr> <tr class="figure-image"> <td colspan="3"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table Tests.</span> <span class="table-title">Data tables by test</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012399.pub2/references#CD012399-tbl-0012">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012399.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD012399-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012399-note-0002">فارسی</a> </li> <li class="section-language"> <a class="" href="ms#CD012399-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD012399-note-0016">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD012399-note-0001">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012399\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012399\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012399\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012399\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012399\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=UDgTyLGV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012399.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012399.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012399.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012399.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012399.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717477477"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012399.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717477481"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012399.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918db8e259169365',t:'MTc0MDcxNzQ3Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 